Criticalkare Pharma

Composition	Cabazitaxel
Strength	60 mg
Brand Name	Cabotib
Usage/Application	Personal
Packaging Size	30 Tablets
Form	Tablet
Manufacturer	Glenmark Pharma
Compostion	Cabazitaxel 60mg
Storage Condition	Store below 30 degree
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Cabotib 60mg tablet is an antineoplastic drug with an active ingredient called Cabozantinib. It belongs to the medication class known as tyrosine kinase inhibitors. In adults, it is used to treat advanced kidney cancer and locally advanced or metastatic differentiated thyroid cancer. It is also used in treating liver cancer when Sorafenib (anticancer medicine) is no longer working. Usually, this medicine is given in combination with Nivolumab for advanced kidney cancer. It is not recommended for those younger than 18 years.  

Do not consume Cabotib 60mg if you are allergic to Cabozantinib and its other ingredients. Inform your physician if you have liver disease, inflammatory bowel disease, high blood pressure, heart disease, or diarrhea. Notify your doctor about the history of blood clots in the leg or significant bleeding, aneurysm (inflammation of blood vessels), or tears in the blood vessel wall. Inform your physician if you are pregnant or planning to get pregnant. Use effective contraception during and even after the treatment or four months. Discuss more fertility concerns with your doctor. 

Uses

• Advanced renal cell carcinoma
• Liver Cancer
• Differentiated thyroid cancer

Therapeutic Effects

It acts against a protein called receptor tyrosine kinases and interferes with cell signaling, ultimately stopping the growth and spread of cancer cells. Cabotib 60mg is indicated alone or in combination with Nivolumab.

• Keep out of sight and reach of pets and children
• Store protected from light at a temperature not exceeding 30°C.

Safety Advices Pregnancy  

Cabotib 60mg is unsafe to use during pregnancy as it may harm the unborn baby. Report to your doctor if you are pregnant or think you may be pregnant or planning for the pregnancy before starting the treatment.   

Breast Feeding  

Taking Cabotib 60mg while breastfeeding may be unsafe because it may affect the child. Do not breastfeed for at least four months after the treatment. Therefore, talk with your doctor to get more information.   

Lungs  

It is unknown whether Cabotib 60mg is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  

Liver  

Inform your physician if you have liver problems because Cabotib 60mg should be used cautiously with this condition.  

Alcohol  

It is unknown whether consuming alcohol while taking a Cabotib 60mg tablet is safe. Please speak with your physician.  

Driving  

While taking Cabotib 60mg, driving or using machines is unsafe because it may cause nausea, changes in vision, vomiting, etc. Talk to your doctor for more information. 

Side Effects

• Gastrointestinal perforation
• Severe or uncontrollable bleeding
• Shortness of breath
• Nonhealing wound
• Pain in the mouth, jaw/teeth, hand, feet,
• Loss of consciousness,
• Drowsy
• Swelling or sores in the mouth
• Blood vomiting
• Black stools
• Blood in urine
• Headache
• Coughing blood

• Dehydration
• Difficulty swallowing
• Ringing in the ears
• Blood clots in the veins
• Fluctuation in the blood sugar levels
• The lower level of albumin
• Electrolyte imbalance
• Increased levels of liver enzymes
• Elevated cholesterol levels in the blood
• Hair loss
• Changes in hair color
• Muscle spasm
• Skin thickening
• Dry skin
• Itching
• Protein in urine

Strength	40 mg
Packaging Size	84 tablets
Composition	Gilteritinib
Dosage Form	Tablet
Prescription	Prescription
Form	Tablet
Storage Condition	Stored at controlled room temperature, between 20 DegreeC to 25 DegreeC (68 DegreeF to 77 DegreeF)
Brand	Xospata
Manufacturer	ASTELLAS PHARMA
Salt Composition	GILTERITINIB 40MG

Xospata 40mg Tablet contains an active component called gilteritinib, which belongs to a class of protein kinase inhibitors. It is used to treat the acute myeloid leukemia in adults, which is linked with a change in the gene (FLT3). Acute myeloid leukemia (AML) is a type of cancer in the blood and bone marrow of individuals. It can be used to treat recurrent AML in patients.
Inform your doctor if you are allergic to giltertinib or any of the ingredients present in them. Consult your doctor if you have a seizure or differentiation syndrome (fever, trouble breathing, rash, dizziness or lightheadedness, rapid weight gain, swelling of your arms or legs) before using the medicine.
Consult your doctor if you have an arrhythmia or heart disorder, a history of low potassium or magnesium levels, or severe abdominal pain with pancreatitis. Your doctor may suggest you monitor the heart function and take regular blood tests before or during the medication. Consult your doctor about the prescribed and non-prescribed medicine. This information will help to treat you based on your health history. Consult your doctor if you are planning to get pregnant or think you may be pregnant or while you are breastfeeding. The safety and effectiveness of the drug have not been established in children or pediatric patients.

Uses
Acute myeloid leukemia (AML)

Storage 
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).Keep away from moisture, heat, and light.It should not be frozen. 

Side Effects
DiarrheaNauseaConstipationTirednessSwelling or oedemaWeaknessAbnormal liver function resultsPain in limbsJoint painMuscle painCoughShortness of breathDizzinessLow blood pressurePassing less urineDiscomfortMuscle stiffness

Composition	Ivosidenib
Strength	200mg
Brand Name	Tibsovo
Packaging Size	60 Tablets
Form	Tablet
Manufacturer	SERVIER INDIA PRIVATE LIMITED
Packaging Type	Bottle
Treatment	Blood Cancer, Mantle-cell lymphoma, CLL / SLL
Usage / Application	Resale / B2B
Country of Origin	Switzerland

Tibsovo 200mg Tablet contains the active substance Ivosidenib, an anticancer medicine that belongs to the class of isocitrate dehydrogenase-1 (IDH1) inhibitors. This Tibsovo ivosidenib tablet is used to treat certain cancers that have an IDH1 gene mutation, and doctors commonly prescribe it as part of targeted cancer therapy.
This medicine is mainly used as Tibsovo for leukaemia treatment, especially for adults with acute myeloid leukaemia (AML) whose cancer cells carry the IDH1 mutation. Doctors may also prescribe it for some patients with cholangiocarcinoma (bile duct cancer) that has spread or cannot be removed with surgery. Patients often search for Tibsovo tablet uses, Tibsovo dosage, and Tibsovo side effects to better understand how this treatment works and what to expect during therapy.
Tibsovo works by blocking the abnormal IDH1 enzyme that helps cancer cells grow and survive. By targeting this enzyme, the medicine slows or stops the growth of cancer cells. Patients and caregivers sometimes look for information such as Tibsovo 200mg tablet price, Tibsovo cost India, or where to buy Tibsovo 200mg online when exploring treatment options.
Before starting treatment, inform your doctor if you have heart problems, liver disease, or electrolyte imbalances. Your doctor may perform blood tests and ECG monitoring during treatment. Always tell your doctor about all medicines you are taking because some drugs may interact with Tibsovo. Patients may also ask about the Tibsovo manufacturer and whether a Tibsovo generic alternative is available, depending on the treatment plan recommended by their healthcare provider.
UsesAcute myeloid leukaemia (AML) with an IDH1 mutation.
Cholangiocarcinoma (bile duct cancer) with an IDH1 mutation.
Storage
Store Tibsovo 200mg Tablet at room temperature between 20°C and 25°C.Keep out of the sight and reach of children and pets.Store the medicine in its original container.Protect it from moisture, heat, and direct sunlight.
Side Effects
FatigueJoint painDiarrhoeaNausea or vomitingLoss of appetiteAbdominal painFeverShortness of breathIrregular heartbeatSevere swelling or weight gainDifferentiation syndrome (fever, breathing problems, fluid build-up)Severe dizzinessLiver problems

Strength	2.5mg
Dose/Strength	2.5 mg
Brand	Bortenat
Pack Size	Vial
Usage/Application	Personal
Form	Injection
Route	IV
Usage	Lymphoma, Cancer Care, Multiple Myeloma
Compostion	Bortezomib 2.5mg
Packaging Type	Vial
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Manufactured By	Intas Pharmaceuticals Ltd
Shelf life	24 months

Borviz 2.5mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant.  

Inform your doctor if you are allergic to Borviz 2.5mg  Injection and its ingredients. Do not use this medication if you have severe lung or heart problems. Before starting treatment with this medication, let your physician know if you are suffering from neuropathy (nerves malfunction), cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumor lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Inform your doctor of diabetes because this Injection can affect your blood glucose levels.

Uses

• Treatment of multiple myeloma and mantle cell lymphoma.

• Store unopened vials in the refrigerator (2 °C – 8 °C) and protect them from light.
• Keep this medicine out of sight and reach of children.

Safety Advices Pregnancy  

Borviz 2.5mg Injection is unsafe to use during pregnancy unless clearly necessary. Both women of childbearing potential and men must use an effective contraception method during and three months after treatment.  

Breast Feeding

Borviz 2.5mg Injection is unsafe to use during breastfeeding. Please discuss with your physician when it is safe to restart breastfeeding after this treatment.  

Lungs  

It is unknown whether Borviz 2.5mg Injection can be given to lung failure patients. Please consult your physician if you have any lung diseases.   

Liver  

Inform your physician before starting this treatment if you have Hepatitis infection or liver disease. Your physician will monitor your liver functions regularly.  

Alcohol  

It is unsafe to consume alcohol with this medication. Borviz 2.5mg Injection may cause excessive drowsiness with alcohol. Please consult your doctor for more advice.  

Driving 

Avoid driving or using machinery if you experience side effects like fainting, dizziness, tiredness, or blurred vision.

Side Effects

• Muscle cramps
• Confusion, visual disturbances, seizures, and headache
• Breathlessness
• Swelling of feet
• Changes in heartbeat
• High blood pressure
• Fainting and tiredness
• Cough and chest tightness

• Pneumonia
• Loss of appetite
• Sensitivity, tingling and burning sensation of the skin
• Nausea, vomiting, and diarrhea
• Mouth ulcers
• Constipation
• Muscle and bone pain
• Hair loss
• Fever
• Reduction in blood cell count
• Reduced kidney function
• Shivering
• Infections
• Itching and redness
• Dehydration
• Stomach problems
• Difficulty sleeping, anxiety, mood swings, depressed mood

Strength	60 mg/1.5 ml
Packaging Size	1.5 ml Vial
Packaging Type	Vial
Prescription/Non prescription	Prescription
Country of origin	Made in India

Z Texel 60mg Injection contains the active constituent cabazitaxel. It is an anticancer medicine used with steroid medicine prednisone or prednisolone to treat people with hormone-refractory metastatic prostate cancer that has progressed after treatment with other anticancer medications, including docetaxel. Cancer is an abnormal and uncontrolled multiplication of cells. Many early-stage prostate cancers need normal testosterone (male hormone) levels to grow. In hormone-refractory metastatic prostate cancer, cancer keeps growing even when the amount of testosterone in the body is reduced to low levels. This medicine should not be used if you have a severe abnormal liver function or recently vaccinated against yellow fever.

Its major toxicities include myelosuppression, neurotoxicity, and allergic reactions. Neutropenia is the most common adverse reaction of Z Texel 60mg Injection. Monitoring of complete blood counts is essential on a weekly basis during cycle 1 and before each treatment cycle thereafter so that the dose can be adjusted, if needed. Vaccination with a live attenuated vaccine should be avoided in patients receiving cabazitaxel, instead killed or inactivated vaccines can be administered.

Uses

• Advanced prostate cancer.

Therapeutic Effects

It is a mitotic inhibitor that works by disrupting the normal process of cell division. This interferes with the microtubules that help to form the cell's cytoskeleton. Microtubules are essential for the normal process of cell division, as they help to pull apart the chromosomes during mitosis. By inhibiting microtubules, Z Texel 60mg Injection prevents the cancer cells from dividing properly and ultimately leads to their death.

• Store Z Texel 60mg Injection in the original package at room temperature (30°C).
• Do not refrigerate.

Safety Advices  Pregnancy  

It is unsafe to use during pregnancy whether Z Texel 60mg Injection can be taken during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.   

Breast Feeding  

It is unsafe to breastfeed during the treatment with this Z Texel 60mg Injection because it may cause harm to the baby. Please consult your doctor before breastfeeding.   

Lungs  

It is unknown whether Z Texel 60mg Injection can be used for patients with liver disorders. Inform your physician if you have any liver problems before starting treatment with this drug  

Liver  

It is unknown whether Z Texel 60mg Injection can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Alcohol  

It is unknown whether consuming alcohol interacts with the Z Texel 60mg Injection. Please consult your doctor for more advice.  

Driving  

It is unsafe to drive vehicles or operate heavy machinery after taking the Z Texel 60mg Injection because it contains a small amount of alcohol, which may cause dizziness and impair your concentration.

Side Effects

• Low white blood cells
• Infection (fever, cough, muscle aches, burning on urination)
• Severe allergic reactions (rash, itching, breathing problems, swelling of face, chest, or throat tightness)
• Kidney damage
• Severe stomach pain

• Low red blood cell count
• Low blood platelet count
• Constipation
• Back pain, joint pain
• Decreased appetite
• Hair loss
• Numbness, burning, tingling, or decreased sensation in your feet or hands
• Taste change
• Headache, dizziness
• Inflammation of mouth
• Blood in urine

Drug Name	Cabozantinib
Strength	40 mg
Brand	Cabalong
Pack Size	30 tablets
Tablets per Pack	30 Tablets
Usage/Application	Personal
Usage	Treatment of liver cancer, kidney cancer, and thyroid cancer.
Form	Tablet
Pack Type	Bottle
Composition	Cabozantinib 40mg
Salt	Cabozantinib
Compostion	Cabozantinib 40mg
Storage Condition	Store below 30 degree
Prescription/Non prescription	Prescription
Dosage Route	Oral
Packaging Type	Bottle
Prescription Type	Prescription
Country of Origin	Made in India

Cabolong 40mg tablet is an antineoplastic drug with an active ingredient called Cabozantinib. It belongs to the medication class known as tyrosine kinase inhibitors. In adults, it is used to treat advanced kidney cancer and locally advanced or metastatic differentiated thyroid cancer. It is also used in treating liver cancer when Sorafenib (anticancer medicine) is no longer working. Usually, this medicine is given in combination with Nivolumab for advanced kidney cancer. It is not recommended for those younger than 18 years.  

Do not consume Cabolong 40mg if you are allergic to Cabozantinib and its other ingredients. Inform your physician if you have liver disease, inflammatory bowel disease, high blood pressure, heart disease, or diarrhea. Notify your doctor about the history of blood clots in the leg or significant bleeding, aneurysm (inflammation of blood vessels), or tears in the blood vessel wall. Inform your physician if you are pregnant or planning to get pregnant. Use effective contraception during and even after the treatment or four months. Discuss more fertility concerns with your doctor. 

Uses

• Advanced renal cell carcinoma
• Liver Cancer
• Differentiated thyroid cancer

Therapeutic Effects

It acts against a protein called receptor tyrosine kinases and interferes with cell signaling, ultimately stopping the growth and spread of cancer cells. Cabolong 40mg is indicated alone or in combination with Nivolumab.

• Keep out of sight and reach of pets and children
• Store protected from light at a temperature not exceeding 30°C.

Safety Advices Pregnancy  

Cabolong 40mg is unsafe to use during pregnancy as it may harm the unborn baby. Report to your doctor if you are pregnant or think you may be pregnant or planning for the pregnancy before starting the treatment.   

Breast Feeding  

Taking Cabolong 40mg while breastfeeding may be unsafe because it may affect the child. Do not breastfeed for at least four months after the treatment. Therefore, talk with your doctor to get more information.   

Lungs  

It is unknown whether Cabolong 40mg is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  

Liver  

Inform your physician if you have liver problems because Cabolong 40mg should be used cautiously with this condition.  

Alcohol  

It is unknown whether consuming alcohol while taking a Cabolong 40mg tablet is safe. Please speak with your physician.  

Driving  

While taking Cabolong 40mg, driving or using machines is unsafe because it may cause nausea, changes in vision, vomiting, etc. Talk to your doctor for more information. 

Side Effects

• Gastrointestinal perforation
• Severe or uncontrollable bleeding
• Shortness of breath
• Nonhealing wound
• Pain in the mouth, jaw/teeth, hand, feet,
• Loss of consciousness,
• Drowsy
• Swelling or sores in the mouth
• Blood vomiting
• Black stools
• Blood in urine
• Headache
• Coughing blood

• Dehydration
• Difficulty swallowing
• Ringing in the ears
• Blood clots in the veins
• Fluctuation in the blood sugar levels
• The lower level of albumin
• Electrolyte imbalance
• Increased levels of liver enzymes
• Elevated cholesterol levels in the blood
• Hair loss
• Changes in hair color
• Muscle spasm
• Skin thickening
• Dry skin
• Itching
• Protein in urine

Strength	160 mg
Form	Tablet
Pack Size	1*10 Tablet
Usage/Application	Personal
Pack Type	Strips
Compostion	Megestrol 160mg
Brand Name	Neostrol
Manufacturer	Neon Laboratories Ltd
Usages	It specifically helps treat breast and endometrial cancer that are hormone dependent. It may also be
Country of Origin	Made in India

Neostrol 160mg Tablet contains the active substance Megestrol. It belongs to a category of medications called progestogens and is used to treat certain hormone-dependent cancers, namely breast cancer. It is a synthetic form of the naturally occurring progesterone hormone. It is also indicated to treat unexplained weight loss, cachexia (weakness) and anorexia (loss of appetite) in patients with weak immune systems and cancer.
Progestogens are used in patients whose disease has progressed with conventional anti-estrogen therapy. Your physician will assess the estrogen status (ER) to ensure that your breast cancer is due to the expression of the estrogen receptor.

Uses of Neostrol 160mg Tablet

• Treatment of hormone-dependent cancer (endometrial cancer, breast cancer)
• Treatment of anorexia, cachexia or unexplained weight loss

Therapeutic Effects of Neostrol 160mg Tablet

Neostrol 160mg Tablet exhibits anticancer properties by interacting with steroidal receptors. It suppresses steroid production by the adrenal glands and androgen secretion by the ovaries in postmenopausal women. It also prevents the breakdown of cytokines and stimulates appetite in chronic disease-induced anorexia and cachexia.

Store below 25°C, protected from light and moisture.  

Safety Advices Pregnancy  

This medicine is unsafe to consume during pregnancy. Inform your physician before starting this treatment if you are pregnant or think you might be pregnant.  

Breast Feeding  

Consult your physician before taking this tablet if you are a breastfeeding mother.  

Lungs  

Inform your physician if you have any lung diseases before taking Neostrol 160 mg tablet.   

Liver  

Inform your physician before starting this treatment if you have liver problems. Your physician will monitor your liver functions regularly.   

Alcohol  

It is not known whether it is safe to consume alcohol with Neostrol160 mg Tablet. Please consult your doctor.  

Driving  

Avoid driving or using machinery if you experience side effects. 

Side Effects

• Swelling of the face, lips, tongue
• Skin rash
• Breathing difficulty
• Blood clot in the lungs
• Heart problems

• Weight gain and increased appetite
• Hot flushes
• High BP
• High blood sugar levels
• Rounded face
• Constipation
• Swelling of vein
• Mood changes
• Hair loss
• Diarrhea
• Tiredness and weakness
• Impotence
• Passing wind
• Frequent urination
• Nausea, vomiting
• Fluid accumulation
• Pain

Strength	160 mg
Form	Tablet
Pack Size	1*10 Tablet
Usage/Application	Personal
Pack Type	Strips
Compostion	Megestrol 160mg
Brand Name	Celstrol
Manufacturer	Celon Laboratories Ltd
Usages	It specifically helps treat breast and endometrial cancer that are hormone dependent. It may also be
Country of Origin	Made in India

Celstrol 160mg Tablet contains the active substance Megestrol. It belongs to a category of medications called progestogens and is used to treat certain hormone-dependent cancers, namely breast cancer. It is a synthetic form of the naturally occurring progesterone hormone. It is also indicated to treat unexplained weight loss, cachexia (weakness) and anorexia (loss of appetite) in patients with weak immune systems and cancer.
Progestogens are used in patients whose disease has progressed with conventional anti-estrogen therapy. Your physician will assess the estrogen status (ER) to ensure that your breast cancer is due to the expression of the estrogen receptor.

Uses of Celstrol 160mg Tablet

• Treatment of hormone-dependent cancer (endometrial cancer, breast cancer)
• Treatment of anorexia, cachexia or unexplained weight loss

Therapeutic Effects of Celstrol 160mg Tablet

Celstrol 160mg Tablet exhibits anticancer properties by interacting with steroidal receptors. It suppresses steroid production by the adrenal glands and androgen secretion by the ovaries in postmenopausal women. It also prevents the breakdown of cytokines and stimulates appetite in chronic disease-induced anorexia and cachexia.

Store below 25°C, protected from light and moisture. 

Safety Advices   Pregnancy  

This medicine is unsafe to consume during pregnancy. Inform your physician before starting this treatment if you are pregnant or think you might be pregnant.  

Breast Feeding  

Consult your physician before taking this tablet if you are a breastfeeding mother.  

Lungs  

Inform your physician if you have any lung diseases before taking Celstrol 160 mg tablet.   

Liver  

Inform your physician before starting this treatment if you have liver problems. Your physician will monitor your liver functions regularly.   

Alcohol  

It is not known whether it is safe to consume alcohol with Celstrol160 mg Tablet. Please consult your doctor.  

Driving  

Avoid driving or using machinery if you experience side effects. 

Side Effects

• Swelling of the face, lips, tongue
• Skin rash
• Breathing difficulty
• Blood clot in the lungs
• Heart problems

• Weight gain and increased appetite
• Hot flushes
• High BP
• High blood sugar levels
• Rounded face
• Constipation
• Swelling of vein
• Mood changes
• Hair loss
• Diarrhea
• Tiredness and weakness
• Impotence
• Passing wind
• Frequent urination
• Nausea, vomiting
• Fluid accumulation
• Pain

Strength	0.5 mg
Usage/Application	Personal
Form	Tablet
Drug Name	Everolimus 0.5mg
Generic Name	Everolimus
Compostion	Everolimus 0.5mg
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Lanolimus 0.5mg tablet is an antineoplastic drug belonging to the class of mTOR kinase inhibitors, containing the active ingredient everolimus. It is used to treat advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and also in the treatment of subependymal giant cell astrocytoma (tumors are found in the ventricles of the brain). Good oral hygiene and regular dental check-ups are important during the treatment since this medicine can cause sores or ulcers in the mouth. It is often combined with cyclophosphamide, an alkylating agent, to treat subependymal giant cell astrocytoma. 

Before taking this medicine, it is necessary to know that your risk of getting bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, Lanolimus 0.5mg tablet increases the chances of reinfection. Tell your healthcare provider if you experience fever, chills, cough, yellowing of the skin, joint pain, or swelling during this treatment. You must limit your exposure to sunlight and UV light by wearing protective clothing and applying sunscreen frequently, as this medicine may increase the risk of developing cancers. Avoid taking grapefruit juice or grapefruit while taking this medicine. 

This tablet is not recommended for adolescents and children under the age of 18. Contact your doctor immediately if you experience shortness of breath, chest pain, or worsening cough. During the Lanolimus 0.5mg tablet treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. This medicine has the potential to cause kidney problems. Report to your doctor if you have been diagnosed with liver disorders, heart failure, high blood cholesterol levels, or hypertension before starting this treatment. Avoid live vaccines and close contact with those who have received live vaccines.

Uses of Lanolimus 0.5mg Tablet

• Advanced breast cancer
• Advanced renal cell carcinoma
• Advanced pancreatic neuroendocrine tumours
• Treatment of subependymal giant cell astrocytoma

• Store Lanolimus 0.5mg tablet in the original package at room temperature (20°C to 25°C).

Safety Advices Pregnancy

Lanolimus 0.5mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.  

Breast Feeding

Lanolimus 0.5mg tablet passes into your breast milk and harms your baby. It is unsafe to consume this tablet.  

Lungs

It is not known whether Lanolimus 0.5mg tablet can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver

Inform your doctor if you have any liver problems before taking Lanolimus 0.5mg tablet. Regular monitoring of liver function tests is recommended.  

Alcohol

Consuming alcohol may affect the effectiveness of Lanolimus 0.5mg tablet. Stop consuming alcohol if you are taking this medicine.  

Driving

It is unsafe to drive vehicles or operate heavy machinery after taking Lanolimus 0.5mg tablet, it may cause dizziness and impair your concentration.

Side Effects

• Difficulty breathing, or swallowing
• Swelling of face, lips, tongue, throat
• Severe itching, red rash, raised bumps

• Infection (chills, increased temperature)
• Coughing
• Wheezing
• Excessive thirst
• High urine output or severely decreased urine output
• Tiredness
• Bleeding
• Increased appetite with weight loss

Indication	Human Papiloma
Vaccine Type	Live attenuated
Age Group	Pediatric–Adult
Dose Volume	0.5 ml
Presentation	Vial
Route	SC
Packaging Size	0.5 ml in 1 vial
Brand	Cervavac Vaccine
Composition	Human Papillomavirus Quadrivalent (Types 6,11,16,and 18) Vaccine,Recombinant (20mcg)
Treatment	Cervavac Vaccine is a vaccine used to prevent cervical,vulvar,and vaginal cancers associate with h
Prescription/Non prescription	Prescription
Form	Injection
Shelf life	24 months
Product Type	Vaccine
Packing Type	1 vial
Item Name	Cervavac Human Papilloma Virus Vaccine Injection

Cervavac Injection consists of the active constituent Human Papilloma Virus vaccine. It is indicated to protect your body against infections and diseases caused by the human papillomavirus types 6, 11, 16, and 18. These virus types cause diseases like pre-cancerous lesions in the female genital areas (cervix, vulva, vagina) and anal regions and cause genital warts in males and females. HPV types 16 and 18 are responsible for approximately 70-80% of cervical and anal cancer cases, and HPV types 6 and 11 are responsible for almost 90 % of genital wart cases.

The HPV virus is a common sexually transmitted infection that can lead to various health problems, including genital warts and various types of cancer, including cervical, anal, penile, and throat cancer. Cervavac Injection does not cure the disease; it protects against it. It does not affect people who are already infected with the virus. This vaccine is only intended to prevent these diseases. The vaccine is most effective when given before a person becomes sexually active, as it is designed to protect against HPV strains commonly transmitted through sexual contact. Cervavac Injection is generally considered safe and effective and has been shown to significantly reduce the risk of HPV-related health problems. There are no known interactions with other vaccines.

Uses of Cervavac Injection

Cervavac Injection is used in the treatment of the following:

• Cervical cancer
• Anal cancer
• Genital warts
• Oropharyngeal cancer

Therapeutic Effects of Cervavac Injection

The primary therapeutic effect of the Cervavac Injection is the prevention of infection, with the strains of HPV most strongly associated with genital warts and various types of cancer, including cervical, anal, penile, and throat cancer. This vaccine can help reduce the risk of developing these strains by preventing infection with these strains.

Interaction of Cervavac Injection with other drugs

Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Cervavac Injection and reduce effectiveness by causing undesirable side effects.

• Store in a refrigerator between 2°C and 8°C (36°F and 46°F).
• It should not be frozen.
• Keep it in its original packaging until it is ready to be used.
• Keep out of the reach of children and pets.

Safety Advices Pregnancy

Cervavac Injection may harm the developing fetus, so it is unsafe to use it during pregnancy.  

Breast Feeding

It is unknown whether Cervavac Injection is excreted in human milk. So breastfeeding women should consult their doctor before taking it.  

Lungs

Individuals with lung conditions should discuss the risks and benefits of Cervavac Injection with their healthcare provider before receiving it.  

Liver

Individuals with liver conditions should discuss the risks and benefits of the Cervavac Injection with their healthcare provider before receiving it.  

Alcohol

There is no evidence to suggest that alcohol consumption affects the safety or effectiveness of the Cervavac Injection. Therefore, individuals who consume alcohol can still safely receive the vaccine.  

Driving

Cervavac Injection has no known effects on driving ability. It is highly unlikely that receiving this vaccine can cause significant changes in a person's cognitive or physical abilities that would affect their ability to drive.

Side Effects

• Allergic reactions
• Hives
• Syncope (fainting)
• Blood clotting disorders

• Pain, redness, or swelling at the injection site
• Headache
• Fever
• Nausea

Strength	100 mg
Vial Volume	20 ml
Brand	Cetuxa
Usage/Application	Personal
Strength per ml	5 mg/ml
Manufacturer	Alkem
Form	Injection
Compostion	Cetuximab 100mg
Storage Condition	Medicines Packed And Stored At The Optimum Temperature
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Cetuxa 100mg Injection 20ml is an anticancer medication containing the active ingredient Cetuximab which belongs to the class of medicine called monoclonal antibody. It is used to treat metastatic cancer of the large intestine alone or with a combination of their medicine. It is also used to treat certain types of squamous cell cancer of the head and neck. Cancer is a condition in which cells multiply uncontrolled and abnormally. 

Do not take a Cetuxa 100mg Injection 20ml if you are allergic to Cetuxa 100mg Injection 20ml or other medicine ingredients. This medicine is not recommended for children and adolescents. Inform your doctor if you have heart, kidney, or lung disorders. Inform your doctor if you are allergic to red meat or tick bite or positive for antibodies; it makes a severe allergic reaction. Please tell your doctor if you have eye problems like blurred vision, red or severe dry eyes, or eye pain. 

Uses

• Metastatic cancer colorectal cancer
• Squamous cell cancer head and neck

• Store Cetuxa 100mg Injection 20ml in the refrigerator (2°C to 8°C)
• Do not freeze
• keep the injection away from the reach of children and pets.
• If you have missed any dosing appointments, inform your doctor and schedule immediately.

Safety Advices   Pregnancy  

Cetuxa 100mg Injection 20ml may cause harm to the unborn baby when administered to a pregnant woman. You need to tell your physician if you are pregnant or planning to get pregnant before taking this medicine.   

Breast Feeding  

It is unsafe to take Cetuxa 100mg Injection 20ml if you are breastfeeding as it passes into breast milk. You need to tell your physician if you are breastfeeding before taking this medicine.   

Lungs  

Cetuxa 100mg Injection 20ml can cause interstitial lung disease (ILD). So, inform your physician about any underlying lung disorders before taking Cetuxa 100mg Injection 20ml, as this medication should be used with caution in lung disease patients. Consult your physician before taking this medicine.   

Liver  

Inform your physician about any underlying liver disorders before taking Cetuxa 100mg Injection 20ml, as this medication should be used with caution in liver disease patients. Consult your physician before taking this medicine.   

Alcohol  

It is not known whether it is safe to consume alcohol with Cetuxa 100mg Injection 20ml. Please consult your doctor.  

Driving  

It is unsafe to drive while taking Cetuxa 100mg Injection 20ml because this medicine might cause dizziness and tiredness, so avoid driving and operating machinery during this treatment.

Side Effects

• Infusion reactions (swelling of face, eyes, mouth, throat, or lips, difficulty breathing, wheezing, chest pain, fainting, or fever)
• Heart problems
• Blistering or peeling of skin
• Vision problems

• Diarrhea, constipation
• Weight loss, poor appetite
• Nausea, vomiting
• Excessive growth of hair in skin
• Low blood counts
• Difficulty breathing, cough
• Liver problems
• Infection
• Headache
• Weakness
• Skin rash

Strength	400mg/20mg
Brand	Capecitabine
Pack Type	Strip
Usage/Application	Personal
Pack Type	Strips
Tablets per Pack	14 Tablets
Form	Tablet
Prescription Type	Prescription
Brand Name	Comcapsy
Shelf Life	24 Months
Manufacturer	Intas Pharmaceuticals Ltd
Usages	To treat certain types of cancer
Country of Origin	Made in India

Comcapsy 400mg/20mg Tablet is an anti-metabolite drug that contains the active ingredient Capecitabine and Cyclophosphamide. It belongs to the category of medicines known as nucleoside metabolic inhibitors and alkylating agents. This medication is used in combination with other anticancer drugs for the treatment of Metastatic colorectal cancer and breast cancer. Cancer is a disease in which cells multiply in an abnormal and uncontrolled manner. It is also used for the prevention of new occurrences of cancer in the colon after the complete removal of the tumor by surgery.

The common side effects that are likely to occur with this medicine are loss of appetite, headache, runny nose, fever, hair loss, and dry mouth. During the treatment, your doctor may periodically monitor your complete blood counts, and prothrombin time, INR, to prevent serious complications. Report to your doctor if you have been diagnosed with stomach ulcers, cataracts, lung disease, or problems in your heart, liver, skin, or kidneys. Tell your physician before you undergo eye surgery or dental procedures.  Inform your doctor if you have experienced any allergic or unusual reactions after taking this drug. This medicine can cause fertility issues, inform your doctor about any fertility concerns you may have before starting treatment with this medicine.  

Uses

• Adjuvant colon cancer
• Metastatic colorectal cancer
• Metastatic breast cancer

• Store Comcapsy 400mg/20mg Tablet in the original package at room temperature (20°C to 25°C). Do not freeze.
• Keep it out of reach from children and pets.
• It is important to get the dose at the scheduled time. If you missed the schedule, contact your doctor and reschedule the dose.

Safety Advices Pregnancy  

Comcapsy 400mg/20mg Tablet is not recommended for pregnant women as it may cause fetal harm.  

Breast Feeding  

It is not known if Comcapsy 400mg/20mg Tablet passes into your breast milk or if it will affect your baby or your breast milk. Talk to your doctor about the best way to feed your baby if you receive this drug.  

Lungs  

It is not known whether Comcapsy 400mg/20mg Tablet can be prescribed to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

Inform your doctor if you have any liver disorders before taking Comcapsy 400mg/20mg Tablet. Regular monitoring of liver function tests is recommended.  

Alcohol  

It is unknown whether consuming alcohol interacts with Comcapsy 400mg/20mg Tablet. Please consult your doctor for more advice.  

Driving  

Comcapsy 400mg/20mg Tablet may cause drowsiness which can affect the patient’s ability to drive or use machines. Consult your doctor before you resume driving. 

Side Effects

• Severe bloody diarrhoea, abdominal pain
• Heart problems (chest pain, shortness of breath, feeling faint, irregular heartbeat, sudden weight gain)
• Loss of too much body fluid, kidney failure
• Serious skin and mouth reactions (skin peeling, blisters)
• Hand and foot syndrome (swelling, changes in sensation of hands and feet)
• Liver problems
• Decreased blood count

• Loss of appetite
• Weight loss
• Insomnia, depression
• Headache, dizziness
• Eye irritation, redness, increased tears
• Inflammation of veins
• Runny nose, fever
• Infections
• Hair loss
• Pain in joints, back
• Dry mouth, indigestion
• Constipation

Pack Size	Single PFS
Strength	60 mcg
Brand	Cresp 60mcg Injection
Pack Type	Box
Indication	CKD Anaemia
Route	SC
Storage	2–8°C
Packaging size	1 Injection in 1 packet
Packaging Type	Packet
Composition	Darbepoetin Alfa 60mcg
Brand Name	Cresp
Manufacturer	Dr Reddy's Laboratories Ltd
Usages	To treat anemia associated with chronic kidney disease (CKD) and cancer chemotherapy
Dose Form	PFS

Cresp 60mcg injection contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath.  

Do not take Cresp 60mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding.  

If you have severe headache, dizziness, drowsiness, confusion, problems with your eyesight, nausea, vomiting, or seizures after taking Cresp 60mcg injection, inform your physician immediately and seek medical advice. This medicine's most common side effects are hypertension, shortness of breath, swelling in the legs, and cough. 

Uses of Cresp 60mcg Injection

• To treat anemia in chronic kidney failure
• To treat anemia caused by chemotherapy

Therapeutic Effects of Cresp 60mcg Injection

Cresp 60mcg injection is an erythropoiesis-stimulating protein produced by recombinant DNA technology. It is closely related to erythropoietin and stimulates erythropoiesis by the same mechanism, and both agents bind to progenitor stem cells stimulating the production/differentiation of red blood cells. It works by causing the bone marrow to make more red blood cells. 

• Store in a refrigerator (2°C to 8°C).
• Do not freeze. Store in the original package to protect from light.
• Keep the injection away from the reach of children and pets.
• If you have missed any dosing appointments, inform your doctor and schedule immediately.

Safety Advices   Pregnancy  

There are no adequate and well-controlled studies on the use of Cresp 60mcg injection in pregnant women. Inform your physician if you are pregnant, suspecting, or planning for pregnancy during the treatment.    

Breast Feeding  

Breastfeeding is not recommended in patients taking Cresp 60mcg injection because the medicine passes into the breast milk in small amounts and may harm your baby.   

Lungs  

It is unknown whether Cresp 60mcg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.   

Liver  

Cresp 60mcg injection is unsafe to administer in patients with liver problems. Dose adjustments are necessary. Inform your physician if you have any liver diseases or problems before initiating the therapy.   

Alcohol  

It is unknown whether consuming alcohol is safe during the treatment with Cresp 60mcg injection . Inform your doctor if you are a chronic drinker.   

Driving  

Cresp 60mcg injection will not make you feel tired, dizzy, or sleepy. It is safe to drive or operate heavy machinery after taking this medicine. 

Side Effects

• Swelling in the face and body
• Low blood pressure
• Abdominal pain
• Shortness of breath
• cough

• Heart problems
• Severe skin reactions
• Anemia
• Seizure attack
• Lung problems

Pack Size	Single PFS
Strength	200 mcg
Brand	Cresp 200mcg Injection
Pack Type	Box
Indication	CKD Anaemia
Route	IV
Storage	2–8°C
Packaging size	1 Injection in 1 prefilled syringe
Packaging Type	Packet
Composition	Darbepoetin Alfa 200mcg
Brand Name	Cresp 200mcg Injection
Manufacturer	Dr Reddy's Laboratories Ltd
Usages	To treat anemia associated with chronic kidney disease (CKD) and cancer chemotherapy

Cresp 200mcg injection contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath.  

Do not take Cresp 200mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding.  

If you have severe headache, dizziness, drowsiness, confusion, problems with your eyesight, nausea, vomiting, or seizures after taking Cresp 200mcg injection, inform your physician immediately and seek medical advice. This medicine's most common side effects are hypertension, shortness of breath, swelling in the legs, and cough. 

Uses

• To treat anemia in chronic kidney failure
• To treat anemia caused by chemotherapy

• Store in a refrigerator (2°C to 8°C).
• Do not freeze. Store in the original package to protect from light.
• Keep the injection away from the reach of children and pets.
• If you have missed any dosing appointments, inform your doctor and schedule immediately.

Safety Advices   Pregnancy  

There are no adequate and well-controlled studies on the use of Cresp 200mcg injection in pregnant women. Inform your physician if you are pregnant, suspecting, or planning for pregnancy during the treatment.    

Breast Feeding  

Breastfeeding is not recommended in patients taking Cresp 200mcg injection because the medicine passes into the breast milk in small amounts and may harm your baby.   

Lungs  

It is unknown whether Cresp 200mcg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.   

Liver  

Cresp 200mcg injection is unsafe to administer in patients with liver problems. Dose adjustments are necessary. Inform your physician if you have any liver diseases or problems before initiating the therapy.   

Alcohol  

It is unknown whether consuming alcohol is safe during the treatment with Cresp 200mcg injection . Inform your doctor if you are a chronic drinker.   

Driving  

Cresp 200mcg injection will not make you feel tired, dizzy, or sleepy. It is safe to drive or operate heavy machinery after taking this medicine. 

Side Effects

• Swelling in the face and body
• Low blood pressure
• Abdominal pain
• Shortness of breath
• cough

• Heart problems
• Severe skin reactions
• Anemia
• Seizure attack
• Lung problems

Pack Size	Single PFS
Strength	500 mcg
Brand	Cresp 500 Injection
Pack Type	Box
Indication	CKD Anaemia
Route	SC
Storage	2–8°C
Packaging size	1.0 ml in 1 prefilled syringe
Packaging Type	Packet
Composition	Darbepoetin Alfa 500mcg
Brand Name	Cresp 500 Injection
Manufacturer	Dr Reddy's Laboratories Ltd
Usages	To treat anemia associated with chronic kidney disease (CKD) and cancer chemotherapy
Molecule	Darbepoetin Alfa
Dose Form	PFS

Cresp 500mcg injection contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath.  

Do not take Cresp 500mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding.  

If you have severe headache, dizziness, drowsiness, confusion, problems with your eyesight, nausea, vomiting, or seizures after taking Cresp 500mcg injection, inform your physician immediately and seek medical advice. This medicine's most common side effects are hypertension, shortness of breath, swelling in the legs, and cough. 

Uses of Cresp 500mcg Injection

• To treat anemia in chronic kidney failure
• To treat anemia caused by chemotherapy

Therapeutic Effects of Cresp 500mcg Injection

Cresp 500mcg injection is an erythropoiesis-stimulating protein produced by recombinant DNA technology. It is closely related to erythropoietin and stimulates erythropoiesis by the same mechanism, and both agents bind to progenitor stem cells stimulating the production/differentiation of red blood cells. It works by causing the bone marrow to make more red blood cells. 

• Store in a refrigerator (2°C to 8°C).
• Do not freeze. Store in the original package to protect from light.
• Keep the injection away from the reach of children and pets.
• If you have missed any dosing appointments, inform your doctor and schedule immediately.

Safety Advices   Pregnancy  

There are no adequate and well-controlled studies on the use of Cresp 500mcg injection in pregnant women. Inform your physician if you are pregnant, suspecting, or planning for pregnancy during the treatment.    

Breast Feeding  

Breastfeeding is not recommended in patients taking Cresp 500mcg injection because the medicine passes into the breast milk in small amounts and may harm your baby.   

Lungs  

It is unknown whether Cresp 500mcg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

Cresp 500mcg injection is unsafe to administer in patients with liver problems. Dose adjustments are necessary. Inform your physician if you have any liver diseases or problems before initiating the therapy.   

Alcohol  

It is unknown whether consuming alcohol is safe during the treatment with Cresp 500mcg injection . Inform your doctor if you are a chronic drinker.   

Driving  

Cresp 500mcg injection will not make you feel tired, dizzy, or sleepy. It is safe to drive or operate heavy machinery after taking this medicine. 

Side Effects

• Swelling in the face and body
• Low blood pressure
• Abdominal pain
• Shortness of breath
• cough

• Heart problems
• Severe skin reactions
• Anemia
• Seizure attack
• Lung problems

Strength	100 mg/1 ml
Vial Volume	10 ml
Brand	Cytarabine
Usage/Application	Personal
Concentration	100 mg/ml
Form	Injection
Route	IV
Compostion	Cytarabine 1000mg
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Cytosar 1000mg injection contains the active substance Cytarabine. It is an antineoplastic drug that belongs to the class antimetabolite. It is used alone or with other chemotherapy medications to treat certain types of leukemias (a type of blood cancer with too many white blood cells), including acute myeloid leukemia (AML) and chronic myelogenous leukemia (CML). It is also indicated to use alone or with other chemotherapy drugs to treat and prevent meningeal leukemia (cancer in the membrane that covers and protects the spinal cord and brain). 

Do not take Cytosar 1000mg injection if you are allergic to Cytarabine or any other ingredients of this medicine. Inform your physician if you have difficulties in body coordination, or taking any other anti-cancer medications, decreased bone marrow functioning, have liver problems, or have undergone dialysis immediately before or after treatment with this medicine.  

Uses

• Acute myeloid leukemia (AML)
• Chronic myelogenous leukemia (CML)
• Meningeal leukemia

• Store Cytosar 1000mg injection at room temperature (25°C)
• Do not refrigerate or freeze.
• Keep the injection away from the reach of children and pets.
• If you forgot to take a dose on the scheduled day, contact your physician and reschedule the dose.
• Do not take a double dose to make up for a forgotten dose.

Safety Advices  Pregnancy  

Cytosar 1000mg injection is unsafe to administer in pregnant women because it may cause birth defects. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 6 months after your last dose is necessary.    

Breast Feeding  

Breastfeeding is not recommended in patients taking Cytosar 1000mg injection because the medicine passes into the breast milk in small amounts and may harm your baby.   

Lungs  

It is unknown whether Cytosar 1000mg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

It is unknown whether Cytosar 1000mg injection can be used in patients with liver disorders. Consult your doctor if you have any liver diseases before starting the treatment.  

Alcohol  

It is not known whether it is safe to consume alcohol with Cytosar 1000mg injection. Please consult your doctor.  

Driving

Cytosar 1000mg injection does not affect your ability to drive or use machinery. If you are affected, consult your doctor for more advice. 

Side Effects

• Fever
• Loss of appetite, abdominal pain
• Swallowing difficulties
• Nausea, vomiting
• Diarrhoea
• Inflammation or ulceration in the mouth or anus
• High blood uric acid levels
• Hair loss
• Skin rashes
• Speaking difficulties
• Inflammation in the vein

• Swelling and irritation of the skin
• Increased blood uric acid levels
• Blisters of the skin
• Irregular heartbeat
• Lung diseases
• Anemia
• Infection
• Kidney problems

Strength	50 mg
Brand	Dasamyl
Tablets per Pack	60 Tablets
Usage/Application	Personal
Pack Size	1*10 Tablet
Pack Type	Strips
Pack Type	Bottle
Form	Tablet
Compostion	Dasatinib 50mg
Brand Name	Dasamyl Tablet
Manufacturer	Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Usages	used in the treatment of blood cancer (chronic myeloid leukaemia)
Country of Origin	Made in India

Dasamyl 50mg tablet consists of the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase and Ph+ acute lymphoblastic leukemia in patients resistant to other therapies. Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body produce too many white blood cells that happen due to alteration in the Philadelphia chromosome. Acute Lymphoblastic Leukemia is the most common form of blood cancer that affects children. In this case, the lymphocytes of white blood cells multiply too quickly and live too long. 

The common side effects that are likely to associate with Dasamyl 50mg tablet are diarrhea, headache, cough, rash, nausea, tiredness, vomiting, muscle pain, weakness, low appetite, and high or low blood pressure. Inform your doctor if these side effects disturb or persist you. 

Inform your doctor if you are allergic to Dasatinib and its ingredients. Before starting treatment with this medication, you should let your physician know if you have liver or heart problems, breathing difficulties, chest pain, cough, hepatitis B infection, or bleeding problems. This medicine could cause a severe reduction in the number of platelets, WBC, or RBC in the blood. Ensure that your physician monitors your blood levels at regular intervals. Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter medicines, vitamins, antacids, and herbal supplements. It is not recommended for children below one year of age.

Uses

• Children and adults with chronic myeloid leukemia.
• Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.

More Information

• Store protected from light at a temperature not exceeding 30c. 

Pregnancy  

Dasamyl 50mg tablet is not recommended during pregnancy unless necessary. Your physician will discuss the potential risk during pregnancy. Women should use effective birth control during treatment and 30 days after the final dose.   

Breast Feeding  

It is not recommended to breastfeed while taking Dasamyl  50mg tablet as it is unknown whether this medication passes into breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose.  

Lungs  

It is unknown whether Dasamyl 50mg tablet is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.  

Liver  

Inform your physician before starting this treatment if you have liver diseases. Your physician will prescribe a dose accordingly.  

Alcohol  

It is not known whether it is safe to consume alcohol with Dasamyl 50mg tablet. Consult your doctor for advice.  

Driving 

Avoid driving or using machinery if you experience symptoms like breathlessness or altered consciousness.

Side Effects

• Unusual bleeding or bruising
• Rapid heart rate
• Changes in consciousness or speech
• Breathlessness and swelling all over the body
• Fever or signs of infection
• Fluid retention
• Heart problems
• Myelosuppression
• Severe allergic reaction

• Diarrhea
• Headache
• Cough
• Rash
• Nausea, tiredness, vomiting
• Muscle pain, weakness
• Low appetite
• High or low BP

Strength	20 mg
Brand	Dasanat
Tablets per Pack	60 Tablets
Usage/Application	Personal
Composition	Dasatinib
Pack Type	Bottle
Usage	CML
Manufactured By	Natco Pharma Ltd
Compostion	Dasatinib 20mg
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Form	Tablet
Country of Origin	Made in India

Dasanat 20mg tablet consists of the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase and Ph+ acute lymphoblastic leukemia in patients resistant to other therapies. Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body produce too many white blood cells that happen due to alteration in the Philadelphia chromosome. Acute Lymphoblastic Leukemia is the most common form of blood cancer that affects children. In this case, the lymphocytes of white blood cells multiply too quickly and live too long.

The common side effects that are likely to associate with Dasanat 20mg tablet are diarrhea, headache, cough, rash, nausea, tiredness, vomiting, muscle pain, weakness, low appetite, high or low blood pressure. Inform your doctor if these side effects disturb or persist for longer period.

Inform your doctor if you are allergic to Dasanat 20mg and its ingredients. Before starting treatment with this medication, you should let your physician know if you have liver or heart problems, breathing difficulties, chest pain, cough, hepatitis B infection, bleeding problems. This medicine could cause a severe reduction in the number of platelets, WBC or RBC in the blood. Ensure that your physician monitors your blood levels at regular intervals. Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter medicines, vitamins, antacids, and herbal supplements. It is not recommended for children below one year of age.

Uses of Dasanat 20mg Tablet

Dasanat 20mg tablet is indicated for the following conditions:

• Children and adults with chronic myeloid leukemia.
• Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.

More Information

Store protected from light at a temperature not exceeding 30c.

Pregnancy  

Dasanat 20mg tablet is not recommended to use during pregnancy unless clearly necessary. Your physician will discuss the potential risk during pregnancy. Women should use effective birth control during treatment and 30 days after the final dose.   

Breast Feeding  

It is not recommended to breastfeed while taking Dasanat 20mg tablet as it is not known whether this medication passes into breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose.  

Lungs  

It is unknown whether Dasanat 20mg is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.  

Liver

Inform your physician before starting this treatment if you have liver diseases. Your physician will prescribe a dose accordingly.  

Alcohol  

It is not known whether it is safe to consume alcohol with Dasanat 20mg tablet. Consult your doctor for advice.  

Driving  

Avoid driving or using machinery if you experience symptoms like breathlessness or altered consciousness. 

Side Effects

• Unusual bleeding or bruising
• Rapid heart rate
• Changes in consciousness or speech
• Breathlessness and swelling all over the body
• Fever or signs of infection
• Fluid retention
• Heart problems
• Myelosuppression
• Severe allergic reaction

• Diarrhea
• Headache
• Cough
• Rash
• Nausea, tiredness, vomiting
• Muscle pain, weakness
• Low appetite
• High or low BP

Strength	150 mg
Brand	Nelova
Capsules per Pack	28 Capsules
Usage	CML
Form	Capsule
Pack Type	Bottle
Manufacturer	SUN PHARMACEUTICAL INDUSTRIES LTD

Nelova 150mg capsule is an antineoplastic drug with an active ingredient called Nilotinib.It belongs to the medication class known as tyrosine kinase inhibitors. This medicine isused to treat a type of leukemia called Philadelphia chromosome-positive chronic myeloidleukemia (Ph-positive CML), a blood cancer with abnormal production of WBCs. In adultand pediatric patients, it is used in a patient who is newly diagnosed with Chronic MyeloidLeukemia (CML) and those facing side effects from previous treatment. Additionally, it isalso used in patients who no longer respond to the previous treatment, including Imatinib.Do not take this medicine if you are allergic to Nilotinib or the other ingredients of thismedicine. Notify your doctor if you have or had a history of heart conditions (heart attack,abnormal electric signal), chest pain, brain stroke, or claudication (condition of blood flowin the leg). Inform your doctor if you have liver or pancreas disorder or are suffering from alack of potassium or magnesium. You need to tell your doctor about all the medicationsespecially if you take medicine to lower your blood cholesterol. Tell your doctor about yourunderlying condition, especially be inform about if you have or ever had a hepatitis B infection;This medicine can activate HPV again, which can be fatal in some cases. Avoid consuminggrapefruit or grapefruit juice. Inform your doctor if you are intolerant to some sugar, as thisMedicine contains lactose.During the treatment, your doctor may conduct a regular blood test to monitor the liver andpancreas function, and the number of blood cells (WBC, RBC, and platelets). Also to monitorthe heart condition (prolongation of the QT interval), electrolytes in the body, and the levelof sugar and fats to check how Nelova 150mg is tolerated. Inform your doctor if you arepregnant or planning to get pregnant or breastfeeding. Use effective birth control duringthe treatment with this medicine.

Uses
Blood cancer (Philadelphia chromosome-positive chronic myeloid leukemia) in adults and pediatrics.

Storage
• Keep this medicine out of the sight and reach of children and pets• Do not store above 30°C• Keep it in its original packaging in order to protect it from light and moisture.• During treatment, you may also have a high level of liver enzymes, urea, or insulin. Contact your doctor immediately if you experience any unusual symptoms.

Side Effects
• Sudden weight gain• Swelling in hands, feet, ankles, or face• Chest pain• Blood pressure (high and low)• Discoloration of tongue, lips, or skin (blue)• Abnormal heart (irregular heartbeat)• Hair loss• Vision problem• Stomach pain, vomiting of blood, blood in stools.• Yellowing of the skin, eyes, and dark urine.• High blood sugar levels.• Sensitivity to light

Strength	200 mg
Brand	Nelova
Capsules per Pack	28 Capsules
Usage	CML, Cancer Care
Form	Capsule
Pack Type	Bottle
Manufacturer	SUN PHARMACEUTICAL INDUSTRIES LTD

Nelova 200mg capsule is an antineoplastic drug with an active ingredient called Nilotinib.It belongs to the medication class known as tyrosine kinase inhibitors. This medicine isused to treat a type of leukemia called Philadelphia chromosome-positive chronic myeloidleukemia (Ph-positive CML), a blood cancer with abnormal production of WBCs. In adultand pediatric patients, it is used in a patient who is newly diagnosed with Chronic MyeloidLeukemia (CML) and those facing side effects from previous treatment. Additionally, it isalso used in patients who no longer respond to the previous treatment, including Imatinib.Do not take this medicine if you are allergic to Nilotinib or the other ingredients of thismedicine. Notify your doctor if you have or had a history of heart conditions (heart attack,abnormal electric signal), chest pain, brain stroke, or claudication (condition of blood flowin the leg). Inform your doctor if you have liver or pancreas disorder or are suffering from alack of potassium or magnesium. You need to tell your doctor about all the medicationsespecially if you take medicine to lower your blood cholesterol. Tell your doctor about yourunderlying condition, especially be inform about if you have or ever had a hepatitis B infection;This medicine can activate HPV again, which can be fatal in some cases. Avoid consuminggrapefruit or grapefruit juice. Inform your doctor if you are intolerant to some sugar, as thisMedicine contains lactose.During the treatment, your doctor may conduct a regular blood test to monitor the liver andpancreas function, and the number of blood cells (WBC, RBC, and platelets). Also to monitorthe heart condition (prolongation of the QT interval), electrolytes in the body, and the levelof sugar and fats to check how Nelova 200mg is tolerated. Inform your doctor if you arepregnant or planning to get pregnant or breastfeeding. Use effective birth control duringthe treatment with this medicine.

Uses
Blood cancer (Philadelphia chromosome-positive chronic myeloid leukemia) in adults and pediatrics.

Storage
• Keep this medicine out of the sight and reach of children and pets• Do not store above 30°C• Keep it in its original packaging in order to protect it from light and moisture.• During treatment, you may also have a high level of liver enzymes, urea, or insulin. Contact your doctor immediately if you experience any unusual symptoms.

Side Effects
• Sudden weight gain• Swelling in hands, feet, ankles, or face• Chest pain• Blood pressure (high and low)• Discoloration of tongue, lips, or skin (blue)• Abnormal heart (irregular heartbeat)• Hair loss• Vision problem• Stomach pain, vomiting of blood, blood in stools.• Yellowing of the skin, eyes, and dark urine.• High blood sugar levels.• Sensitivity to light

Strength	2.5mg
Dose/Strength	2.5 mg
Brand	Cadila
Pack Size	Vial
Usage/Application	Personal
Form	Injection
Route	IV
Usage	Lymphoma, Multiple Myeloma, Cancer Care
Packaging Type	Vial
Compostion	Bortezomib 2.5mg
Storage Condition	Store below 30 DegreeC
Manufactured By	Zydus Cadila
Prescription/Non prescription	Prescription
Shelf life	24 months

Proteoz 2.5mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant. 

Inform your doctor if you are allergic to Proteoz 2.5mg  Injection and its ingredients. Do not use this medication if you have severe lung or heart problems. Before starting treatment with this medication, let your physician know if you are suffering from neuropathy (nerves malfunction), cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumor lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Inform your doctor of diabetes because this Injection can affect your blood glucose levels.

Uses

• Treatment of multiple myeloma and mantle cell lymphoma.

• Store unopened vials in the refrigerator (2 °C – 8 °C) and protect them from light.
• Keep this medicine out of sight and reach of children.

Safety Advices   Pregnancy  

Proteoz 2.5mg Injection is unsafe to use during pregnancy unless clearly necessary. Both women of childbearing potential and men must use an effective contraception method during and three months after treatment.  

Breast Feeding  

Proteoz 2.5mg Injection is unsafe to use during breastfeeding. Please discuss with your physician when it is safe to restart breastfeeding after this treatment.  

Lungs  

It is unknown whether Proteoz 2.5mg Injection can be given to lung failure patients. Please consult your physician if you have any lung diseases.   

Liver  

Inform your physician before starting this treatment if you have Hepatitis infection or liver disease. Your physician will monitor your liver functions regularly.  

Alcohol  

It is unsafe to consume alcohol with this medication. Proteoz 2.5mg Injection may cause excessive drowsiness with alcohol. Please consult your doctor for more advice.  

Driving

Avoid driving or using machinery if you experience side effects like fainting, dizziness, tiredness, or blurred vision.

Side Effects

• Muscle cramps
• Confusion, visual disturbances, seizures, and headache
• Breathlessness
• Swelling of feet
• Changes in heartbeat
• High blood pressure
• Fainting and tiredness
• Cough and chest tightness

• Pneumonia
• Loss of appetite
• Sensitivity, tingling and burning sensation of the skin
• Nausea, vomiting, and diarrhea
• Mouth ulcers
• Constipation
• Muscle and bone pain
• Hair loss
• Fever
• Reduction in blood cell count
• Reduced kidney function
• Shivering
• Infections
• Itching and redness
• Dehydration
• Stomach problems
• Difficulty sleeping, anxiety, mood swings, depressed mood

Strength	20 mg
Usage/Application	Personal
Form	Tablet
Composition	Cabozantinib 20mg
Compostion	Cabozantinib 20mg
Usage	Treatment of liver cancer, kidney cancer, and thyroid cancer.
Storage Condition	Storage below 30 degree
Salt	Cabozantinib
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Cazanat 20mg tablet is an antineoplastic drug with an active ingredient called Cabozantinib. It belongs to the medication class known as tyrosine kinase inhibitors. In adults, it is used to treat advanced kidney cancer and locally advanced or metastatic differentiated thyroid cancer. It is also used in treating liver cancer when Sorafenib (anticancer medicine) is no longer working. Usually, this medicine is given in combination with Nivolumab for advanced kidney cancer. It is not recommended for those younger than 18 years.  

Do not consume Cazanat 20mg if you are allergic to Cabozantinib and its other ingredients. Inform your physician if you have liver disease, inflammatory bowel disease, high blood pressure, heart disease, or diarrhea. Notify your doctor about the history of blood clots in the leg or significant bleeding, aneurysm (inflammation of blood vessels), or tears in the blood vessel wall. Inform your physician if you are pregnant or planning to get pregnant. Use effective contraception during and even after the treatment or four months. Discuss more fertility concerns with your doctor.

Uses

• Advanced renal cell carcinoma
• Liver Cancer
• Differentiated thyroid cancer

Therapeutic Effects

It acts against a protein called receptor tyrosine kinases and interferes with cell signaling, ultimately stopping the growth and spread of cancer cells. Cazanat 20mg is indicated alone or in combination with Nivolumab.

• Keep out of sight and reach of pets and children
• Store protected from light at a temperature not exceeding 30°C.

Safety Advices   Pregnancy  

Cazanat 20mg is unsafe to use during pregnancy as it may harm the unborn baby. Report to your doctor if you are pregnant or think you may be pregnant or planning for the pregnancy before starting the treatment.   

Breast Feeding  

Taking Cazanat 20mg while breastfeeding may be unsafe because it may affect the child. Do not breastfeed for at least four months after the treatment. Therefore, talk with your doctor to get more information.   

Lungs  

It is unknown whether Cazanat 20mg is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  

Liver  

Inform your physician if you have liver problems because Cazanat 20mg should be used cautiously with this condition.  

Alcohol  

It is unknown whether consuming alcohol while taking a Cazanat 20mg tablet is safe. Please speak with your physician.  

Driving  

While taking Cazanat 20mg, driving or using machines is unsafe because it may cause nausea, changes in vision, vomiting, etc. Talk to your doctor for more information. 

Side Effects

• Gastrointestinal perforation
• Severe or uncontrollable bleeding
• Shortness of breath
• Nonhealing wound
• Pain in the mouth, jaw/teeth, hand, feet,
• Loss of consciousness,
• Drowsy
• Swelling or sores in the mouth
• Blood vomiting
• Black stools
• Blood in urine
• Headache
• Coughing blood

• Dehydration
• Difficulty swallowing
• Ringing in the ears
• Blood clots in the veins
• Fluctuation in the blood sugar levels
• The lower level of albumin
• Electrolyte imbalance
• Increased levels of liver enzymes
• Elevated cholesterol levels in the blood
• Hair loss
• Changes in hair color
• Muscle spasm
• Skin thickening
• Dry skin
• Itching
• Protein in urine

Strength	60 mg
Usage/Application	Personal
Form	Tablet
Composition	Cabazitaxel 60mg
Compostion	Cabazitaxel 60mg
Usage	Treatment of liver cancer, kidney cancer, and thyroid cancer.
Storage Condition	Store below 30 degree
Salt	Cabazitaxel
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Cabolong 60mg tablet is an antineoplastic drug with an active ingredient called Cabozantinib. It belongs to the medication class known as tyrosine kinase inhibitors. In adults, it is used to treat advanced kidney cancer and locally advanced or metastatic differentiated thyroid cancer. It is also used in treating liver cancer when Sorafenib (anticancer medicine) is no longer working. Usually, this medicine is given in combination with Nivolumab for advanced kidney cancer. It is not recommended for those younger than 18 years.  

Do not consume Cabolong 60mg if you are allergic to Cabozantinib and its other ingredients. Inform your physician if you have liver disease, inflammatory bowel disease, high blood pressure, heart disease, or diarrhea. Notify your doctor about the history of blood clots in the leg or significant bleeding, aneurysm (inflammation of blood vessels), or tears in the blood vessel wall. Inform your physician if you are pregnant or planning to get pregnant. Use effective contraception during and even after the treatment or four months. Discuss more fertility concerns with your doctor. 

Uses

• Advanced renal cell carcinoma
• Liver Cancer
• Differentiated thyroid cancer

Therapeutic Effects

It acts against a protein called receptor tyrosine kinases and interferes with cell signaling, ultimately stopping the growth and spread of cancer cells. Cabolong 60mg is indicated alone or in combination with Nivolumab.

• Keep out of sight and reach of pets and children
• Store protected from light at a temperature not exceeding 30°C.

Safety Advices   Pregnancy  

Cabolong 60mg is unsafe to use during pregnancy as it may harm the unborn baby. Report to your doctor if you are pregnant or think you may be pregnant or planning for the pregnancy before starting the treatment.   

Breast Feeding  

Taking Cabolong 60mg while breastfeeding may be unsafe because it may affect the child. Do not breastfeed for at least four months after the treatment. Therefore, talk with your doctor to get more information.   

Lungs  

It is unknown whether Cabolong 60mg is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  

Liver  

Inform your physician if you have liver problems because Cabolong 60mg should be used cautiously with this condition.  

Alcohol  

It is unknown whether consuming alcohol while taking a Cabolong 60mg tablet is safe. Please speak with your physician.  

Driving  

While taking Cabolong 60mg, driving or using machines is unsafe because it may cause nausea, changes in vision, vomiting, etc. Talk to your doctor for more information. 

Side Effects

• Gastrointestinal perforation
• Severe or uncontrollable bleeding
• Shortness of breath
• Nonhealing wound
• Pain in the mouth, jaw/teeth, hand, feet,
• Loss of consciousness,
• Drowsy
• Swelling or sores in the mouth
• Blood vomiting
• Black stools
• Blood in urine
• Headache
• Coughing blood

• Dehydration
• Difficulty swallowing
• Ringing in the ears
• Blood clots in the veins
• Fluctuation in the blood sugar levels
• The lower level of albumin
• Electrolyte imbalance
• Increased levels of liver enzymes
• Elevated cholesterol levels in the blood
• Hair loss
• Changes in hair color
• Muscle spasm
• Skin thickening
• Dry skin
• Itching
• Protein in urine

Treatment	Multiple Myeloma
Brand	Carzomib
Manufacturer	Hetero Healthcare
Packaging Type	Vial
Strength	60 mg
Storage Temperature	2-8 degree c
Dosage Form	Lyophilized Powder for Injection
Country of Origin	Made in India

Carzomib 60mg Injection is an anticancer medication containing the active constituent Carfilzomib. It is used to treat a type of cancer called multiple myeloma. Multiple myeloma is a cancer of a white blood cell called the plasma cell. These cells grow uncontrolled and accumulate in the bone marrow, damaging the bones and kidneys. The treatment with this medication reduces symptoms of multiple myelomas, such as bone pain, fatigue, and anemia, improving a patient's quality of life.

Combined with other medications, this medication can significantly increase survival rates in patients with multiple myeloma. It is often used in combination with other medications. Like all medications, it can have side effects. Common side effects include fatigue, nausea, vomiting, diarrhea, fever, and low blood cell counts. Patients need to stay hydrated while taking Carzomib 60mg Injection, as this medication causes dehydration, and dehydration can exacerbate some of the side effects of the medication. It effectively treats multiple myeloma, and the benefits may outweigh the risks for many patients.

Uses of Carzomib 60mg Injection

Carzomib 60mg Injection is used to treat-

• Multiple myeloma

• Carzomib 60mg Injection should be stored under refrigeration between 2°C to 8°C (36°F to 46°F).
• Keep it in the original package until it is ready to use.
• Should not be frozen.
• Discard any unused portion after 4 hours.
• Keep reaching out of children and pets.

Safety Advices   Pregnancy  

Carzomib 60mg Injection is unsafe for pregnant women as it may cause fetal harm. So it is not recommended to take it during pregnancy.  

Breast Feeding  

It is unknown whether Carzomib 60mg Injection is excreted in human breast milk. So breastfeeding mothers should consult a doctor before taking it.  

Lungs  

Carzomib 60mg Injection can cause lung-related side effects, such as shortness of breath, coughing, and pulmonary hypertension. Patients with pre-existing lung conditions, such as chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD), may be at increased risk of these side effects.  

Liver  

There is limited information on the use of Carzomib 60mg Injection in patients with severe liver impairment, and caution is advised in this population. If you have liver impairment or a history of liver disease, it is better to consult your healthcare provider before starting treatment.  

Alcohol  

There is limited information on the interaction between alcohol and Carzomib 60mg Injection. However, it is generally recommended to avoid or limit alcohol consumption during treatment.  

Driving  

Carzomib 60mg Injection may cause side effects such as fatigue, dizziness, or blurred vision that can impair a patient's ability to drive or operate machinery safely. So you should avoid these activities during treatment with this medication.

Side Effects

• Cardiac events such as heart failure, heart attack, or arrhythmias
• Blood clotting disorders or bleeding
• Acute kidney injury
• Lung damage or inflammation
• Infections
• Tumor lysis syndrome (a condition that can occur when cancer cells break down rapidly)

• Fatigue
• Nausea and vomiting
• Diarrhea
• Low blood cell counts (anemia, low white blood cell count, low platelet count)
• Fever
• Headache
• Difficulty breathing or shortness of breath
• Cough
• Muscle weakness or pain
• Rash
• Back pain

Strength	0.25 mg
Usage/Application	Personal
Form	Tablet
Drug Name	Everolimus 0.25mg
Generic Name	Everolimus
Compostion	Everolimus 0.25mg
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Lanolimus 0.25mg tablet is an antineoplastic drug belonging to the class of mTOR kinase inhibitors, containing the active ingredient everolimus. It is used to treat advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and also in the treatment of subependymal giant cell astrocytoma (tumors are found in the ventricles of the brain). Good oral hygiene and regular dental check-ups are important during the treatment since this medicine can cause sores or ulcers in the mouth. It is often combined with cyclophosphamide, an alkylating agent, to treat subependymal giant cell astrocytoma.  

This tablet is not recommended for adolescents and children under the age of 18. Contact your doctor immediately if you experience shortness of breath, chest pain, or worsening cough. During the Lanolimus 0.25mg tablet treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. This medicine has the potential to cause kidney problems. Report to your doctor if you have been diagnosed with liver disorders, heart failure, high blood cholesterol levels, or hypertension before starting this treatment. Avoid live vaccines and close contact with those who have received live vaccines.

Uses

• Advanced breast cancer
• Advanced renal cell carcinoma
• Advanced pancreatic neuroendocrine tumours
• Treatment of subependymal giant cell astrocytoma

Therapeutic Effects

Lanolimus 0.25mg tablet inhibits the activity of a protein called mammalian target of rapamycin (mTOR), which regulates cell growth. This drug can slow the growth of abnormal cancer cells by blocking the mTOR protein and helps to reduce the size of tumors and improve outcomes in patients.

• Store Lanolimus 0.25mg tablet in the original package at room temperature (20°C to 25°C).
• Keep it out of reach from children.

Safety Advices   Pregnancy  

Lanolimus 0.25mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.  

Breast Feeding  

Lanolimus 0.25mg tablet passes into your breast milk and harms your baby. It is unsafe to consume this tablet.  

Lungs  

It is not known whether Lanolimus 0.25mg tablet can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

Inform your doctor if you have any liver problems before taking Lanolimus 0.25mg tablet. Regular monitoring of liver function tests is recommended.  

Alcohol  

Consuming alcohol may affect the effectiveness of Lanolimus 0.25mg tablet. Stop consuming alcohol if you are taking this medicine.  

Driving  

It is unsafe to drive vehicles or operate heavy machinery after taking Lanolimus 0.25mg tablet, it may cause dizziness and impair your concentration.

Side Effects

• Difficulty breathing, or swallowing
• Swelling of face, lips, tongue, throat
• Severe itching, red rash, raised bumps

• Infection (chills, increased temperature)
• Coughing
• Wheezing
• Excessive thirst
• High urine output or severely decreased urine output
• Tiredness
• Bleeding
• Increased appetite with weight loss

Pack Size	Vial
Strength	40 mcg
Brand	Cresp 40mcg Injection
Pack Type	Vial
Indication	CKD Anaemia
Route	SC
Storage	2–8°C
Packaging size	1 ml in 1 vial
Packaging Type	Vial
Composition	Darbepoetin Alfa 40mcg
Brand Name	Cresp 40mcg Injection
Manufacturer	Dr Reddy's Laboratories Ltd
Usages	To treat anemia associated with chronic kidney disease (CKD) and cancer chemotherapy
Molecule	Darbepoetin Alfa
Dose Form	Vial

Cresp 40mcg injection contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath.  

Do not take Cresp 40mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding.  

If you have severe headache, dizziness, drowsiness, confusion, problems with your eyesight, nausea, vomiting, or seizures after taking Cresp 40mcg injection, inform your physician immediately and seek medical advice. This medicine's most common side effects are hypertension, shortness of breath, swelling in the legs, and cough. 

Uses of Cresp 40mcg Injection

• To treat anemia in chronic kidney failure
• To treat anemia caused by chemotherapy

Therapeutic Effects of Cresp 40mcg Injection

Cresp 40mcg injection is an erythropoiesis-stimulating protein produced by recombinant DNA technology. It is closely related to erythropoietin and stimulates erythropoiesis by the same mechanism, and both agents bind to progenitor stem cells stimulating the production/differentiation of red blood cells. It works by causing the bone marrow to make more red blood cells. 

• Store in a refrigerator (2°C to 8°C).
• Do not freeze. Store in the original package to protect from light.
• Keep the injection away from the reach of children and pets.
• If you have missed any dosing appointments, inform your doctor and schedule immediately. 

Safety Advices  Pregnancy

There are no adequate and well-controlled studies on the use of Cresp 40mcg injection in pregnant women. Inform your physician if you are pregnant, suspecting, or planning for pregnancy during the treatment.    

Breast Feeding

Breastfeeding is not recommended in patients taking Cresp 40mcg injection because the medicine passes into the breast milk in small amounts and may harm your baby.   

Lungs

It is unknown whether Cresp 40mcg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.   

Liver

Cresp 40mcg injection is unsafe to administer in patients with liver problems. Dose adjustments are necessary. Inform your physician if you have any liver diseases or problems before initiating the therapy.   

Alcohol

It is unknown whether consuming alcohol is safe during the treatment with Cresp 40mcg injection . Inform your doctor if you are a chronic drinker.   

Driving

Cresp 40mcg injection will not make you feel tired, dizzy, or sleepy. It is safe to drive or operate heavy machinery after taking this medicine. 

Side Effects

• Swelling in the face and body
• Low blood pressure
• Abdominal pain
• Shortness of breath
• cough

• Heart problems
• Severe skin reactions
• Anemia
• Seizure attack
• Lung problems

Strength	1000 mg
Vial Volume	1ml
Brand	Cytaneon
Usage/Application	Personal
Packaging Type	Vial
Concentration	100 mg/ml
Form	Injection
Route	IV
Compostion	Cytarabine 1000mg
Also gives	PCD Pharma Franchise
Manufacturer	Neon Laboratories Ltd
Country of Origin	Made in India

Cytaneon 1000mg injection contains the active substance Cytarabine. It is an antineoplastic drug that belongs to the class antimetabolite. It is used alone or with other chemotherapy medications to treat certain types of leukemias (a type of blood cancer with too many white blood cells), including acute myeloid leukemia (AML) and chronic myelogenous leukemia (CML). It is also indicated to use alone or with other chemotherapy drugs to treat and prevent meningeal leukemia (cancer in the membrane that covers and protects the spinal cord and brain). 

Do not take Cytaneon 1000mg injection if you are allergic to Cytarabine or any other ingredients of this medicine. Inform your physician if you have difficulties in body coordination, or taking any other anti-cancer medications, decreased bone marrow functioning, have liver problems, or have undergone dialysis immediately before or after treatment with this medicine.  

Uses

• Acute myeloid leukemia (AML)
• Chronic myelogenous leukemia (CML)
• Meningeal leukemia

• Store Cytaneon 1000mg injection at room temperature (25°C)
• Do not refrigerate or freeze.
• Keep the injection away from the reach of children and pets.
• If you forgot to take a dose on the scheduled day, contact your physician and reschedule the dose.
• Do not take a double dose to make up for a forgotten dose.

Safety Advices  Pregnancy 

Cytaneon 1000mg injection is unsafe to administer in pregnant women because it may cause birth defects. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 6 months after your last dose is necessary.    

Breast Feeding  

Breastfeeding is not recommended in patients taking Cytaneon 1000mg injection because the medicine passes into the breast milk in small amounts and may harm your baby.   

Lungs  

It is unknown whether Cytaneon 1000mg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

It is unknown whether Cytaneon 1000mg injection can be used in patients with liver disorders. Consult your doctor if you have any liver diseases before starting the treatment.  

Alcohol  

It is not known whether it is safe to consume alcohol with Cytaneon 1000mg injection. Please consult your doctor.  

Driving  

Cytaneon 1000mg injection does not affect your ability to drive or use machinery. If you are affected, consult your doctor for more advice. 

Side Effects

• Fever
• Loss of appetite, abdominal pain
• Swallowing difficulties
• Nausea, vomiting
• Diarrhoea
• Inflammation or ulceration in the mouth or anus
• High blood uric acid levels
• Hair loss
• Skin rashes
• Speaking difficulties
• Inflammation in the vein

• Swelling and irritation of the skin
• Increased blood uric acid levels
• Blisters of the skin
• Irregular heartbeat
• Lung diseases
• Anemia
• Infection
• Kidney problems

Strength	50 mg
Brand	Spnib
Tablets per Pack	60 Tablets
Usage/Application	Personal
Pack Size	1*10 Tablet
Pack Type	Box
Usage	CML
Pack Type	Bottle
Form	Tablet
Compostion	Dasatinib 50mg
Brand Name	Spnib Tablet
Manufacturer	ZYDUS CADILA
Usages	It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia.
Country of Origin	Made in India

Spnib 50mg tablet consists of the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase and Ph+ acute lymphoblastic leukemia in patients resistant to other therapies. Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body produce too many white blood cells that happen due to alteration in the Philadelphia chromosome. Acute Lymphoblastic Leukemia is the most common form of blood cancer that affects children. In this case, the lymphocytes of white blood cells multiply too quickly and live too long. 

The common side effects that are likely to associate with Spnib 50mg tablet are diarrhea, headache, cough, rash, nausea, tiredness, vomiting, muscle pain, weakness, low appetite, and high or low blood pressure. Inform your doctor if these side effects disturb or persist you. 

Inform your doctor if you are allergic to Dasatinib and its ingredients. Before starting treatment with this medication, you should let your physician know if you have liver or heart problems, breathing difficulties, chest pain, cough, hepatitis B infection, or bleeding problems. This medicine could cause a severe reduction in the number of platelets, WBC, or RBC in the blood. Ensure that your physician monitors your blood levels at regular intervals. Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter medicines, vitamins, antacids, and herbal supplements. It is not recommended for children below one year of age.

Uses of Spnib 50mg Tablet

Spnib 50mg tablet is indicated for the following conditions

• Children and adults with chronic myeloid leukemia.
• Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.

More Information

• Store protected from light at a temperature not exceeding 30c.

Pregnancy  

Spnib 50mg tablet is not recommended during pregnancy unless necessary. Your physician will discuss the potential risk during pregnancy. Women should use effective birth control during treatment and 30 days after the final dose.   

Breast Feeding  

It is not recommended to breastfeed while taking Spnib  50mg tablet as it is unknown whether this medication passes into breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose.  

Lungs  

It is unknown whether Spnib 50mg tablet is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.  

Liver  

Inform your physician before starting this treatment if you have liver diseases. Your physician will prescribe a dose accordingly.  

Alcohol  

It is not known whether it is safe to consume alcohol with Spnib 50mg tablet. Consult your doctor for advice.  

Driving  

Avoid driving or using machinery if you experience symptoms like breathlessness or altered consciousness.

Side Effects

• Unusual bleeding or bruising
• Rapid heart rate
• Changes in consciousness or speech
• Breathlessness and swelling all over the body
• Fever or signs of infection
• Fluid retention
• Heart problems
• Myelosuppression
• Severe allergic reaction

• Diarrhea
• Headache
• Cough
• Rash
• Nausea, tiredness, vomiting
• Muscle pain, weakness
• Low appetite
• High or low BP

Strength	50 mg
Brand	Dasatinib
Tablets per Pack	60 Tablets
Usage/Application	Personal
Composition	Dasatinib
Pack Type	Bottle
Usage	CML
Manufactured By	Natco Pharma Ltd
Compostion	Dasatinib 50mg
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Form	Tablet
Country of Origin	Made in India

Dasanat 50mg tablet consists of the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase and Ph+ acute lymphoblastic leukemia in patients resistant to other therapies. Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body produce too many white blood cells that happen due to alteration in the Philadelphia chromosome. Acute Lymphoblastic Leukemia is the most common form of blood cancer that affects children. In this case, the lymphocytes of white blood cells multiply too quickly and live too long. 

The common side effects that are likely to associate with Dasanat 50mg tablet are diarrhea, headache, cough, rash, nausea, tiredness, vomiting, muscle pain, weakness, low appetite, and high or low blood pressure. Inform your doctor if these side effects disturb or persist you. 

Inform your doctor if you are allergic to Dasatinib and its ingredients. Before starting treatment with this medication, you should let your physician know if you have liver or heart problems, breathing difficulties, chest pain, cough, hepatitis B infection, or bleeding problems. This medicine could cause a severe reduction in the number of platelets, WBC, or RBC in the blood. Ensure that your physician monitors your blood levels at regular intervals. Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter medicines, vitamins, antacids, and herbal supplements. It is not recommended for children below one year of age.

Uses

• Children and adults with chronic myeloid leukemia.
• Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.

More Information

• Store protected from light at a temperature not exceeding 30c.

Pregnancy  

Dasanat 50mg tablet is not recommended during pregnancy unless necessary. Your physician will discuss the potential risk during pregnancy. Women should use effective birth control during treatment and 30 days after the final dose.   

Breast Feeding  

It is not recommended to breastfeed while taking Dasanat  50mg tablet as it is unknown whether this medication passes into breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose.  

Lungs  

It is unknown whether Dasanat 50mg tablet is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.  

Liver  

Inform your physician before starting this treatment if you have liver diseases. Your physician will prescribe a dose accordingly.  

Alcohol  

It is not known whether it is safe to consume alcohol with Dasanat 50mg tablet. Consult your doctor for advice.  

Driving  

Avoid driving or using machinery if you experience symptoms like breathlessness or altered consciousness.

Side Effects

• Unusual bleeding or bruising
• Rapid heart rate
• Changes in consciousness or speech
• Breathlessness and swelling all over the body
• Fever or signs of infection
• Fluid retention
• Heart problems
• Myelosuppression
• Severe allergic reaction

• Diarrhea
• Headache
• Cough
• Rash
• Nausea, tiredness, vomiting
• Muscle pain, weakness
• Low appetite
• High or low BP

Strength	20 mg
Brand	Spnib
Tablets per Pack	60 Tablets
Usage/Application	Personal
Pack Size	1*10 Tablet
Pack Type	Box
Usage	CML
Pack Type	Bottle
Form	Tablet
Compostion	Dasatinib 20mg
Brand Name	Spnib Tablet
Manufacturer	Zydus Cadila
Usages	used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML)
Country of Origin	Made in India

Spnib 20mg tablet consists of the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase and Ph+ acute lymphoblastic leukemia in patients resistant to other therapies. Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body produce too many white blood cells that happen due to alteration in the Philadelphia chromosome. Acute Lymphoblastic Leukemia is the most common form of blood cancer that affects children. In this case, the lymphocytes of white blood cells multiply too quickly and live too long.

The common side effects that are likely to associate with Spnib 20mg tablet are diarrhea, headache, cough, rash, nausea, tiredness, vomiting, muscle pain, weakness, low appetite, high or low blood pressure. Inform your doctor if these side effects disturb or persist for longer period.

Inform your doctor if you are allergic to Spnib 20mg and its ingredients. Before starting treatment with this medication, you should let your physician know if you have liver or heart problems, breathing difficulties, chest pain, cough, hepatitis B infection, bleeding problems. This medicine could cause a severe reduction in the number of platelets, WBC or RBC in the blood. Ensure that your physician monitors your blood levels at regular intervals. Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter medicines, vitamins, antacids, and herbal supplements. It is not recommended for children below one year of age.

Uses of Spnib 20mg Tablet

Spnib 20mg tablet is indicated for the following conditions:

• Children and adults with chronic myeloid leukemia.
• Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.

More Information

Store protected from light at a temperature not exceeding 30c.

Pregnancy  

Spnib 20mg tablet is not recommended to use during pregnancy unless clearly necessary. Your physician will discuss the potential risk during pregnancy. Women should use effective birth control during treatment and 30 days after the final dose.   

Breast Feeding  

It is not recommended to breastfeed while taking Spnib 20mg tablet as it is not known whether this medication passes into breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose.  

Lungs  

It is unknown whether Spnib 20mg is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.  

Liver  

Inform your physician before starting this treatment if you have liver diseases. Your physician will prescribe a dose accordingly.  

Alcohol  

It is not known whether it is safe to consume alcohol with Spnib 20mg tablet. Consult your doctor for advice.  

Driving  

Avoid driving or using machinery if you experience symptoms like breathlessness or altered consciousness. 

Side Effects

• Unusual bleeding or bruising
• Rapid heart rate
• Changes in consciousness or speech
• Breathlessness and swelling all over the body
• Fever or signs of infection
• Fluid retention
• Heart problems
• Myelosuppression
• Severe allergic reaction

• Diarrhea
• Headache
• Cough
• Rash
• Nausea, tiredness, vomiting
• Muscle pain, weakness
• Low appetite
• High or low BP

Strength	40 mg
Usage/Application	Personal
Form	Tablet
Composition	Cabozantinib 40mg
Compostion	Cabozantinib 40mg
Usage	Treatment of liver cancer, kidney cancer, and thyroid cancer.
Storage Condition	Store below 30 degree
Salt	Cabozantinib
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Cazanat 40mg tablet is an antineoplastic drug with an active ingredient called Cabozantinib. It belongs to the medication class known as tyrosine kinase inhibitors. In adults, it is used to treat advanced kidney cancer and locally advanced or metastatic differentiated thyroid cancer. It is also used in treating liver cancer when Sorafenib (anticancer medicine) is no longer working. Usually, this medicine is given in combination with Nivolumab for advanced kidney cancer. It is not recommended for those younger than 18 years.  

Do not consume Cazanat 40mg if you are allergic to Cabozantinib and its other ingredients. Inform your physician if you have liver disease, inflammatory bowel disease, high blood pressure, heart disease, or diarrhea. Notify your doctor about the history of blood clots in the leg or significant bleeding, aneurysm (inflammation of blood vessels), or tears in the blood vessel wall. Inform your physician if you are pregnant or planning to get pregnant. Use effective contraception during and even after the treatment or four months. Discuss more fertility concerns with your doctor. 

Uses

• Advanced renal cell carcinoma
• Liver Cancer
• Differentiated thyroid cancer

Therapeutic Effects

It acts against a protein called receptor tyrosine kinases and interferes with cell signaling, ultimately stopping the growth and spread of cancer cells. Cazanat 40mg is indicated alone or in combination with Nivolumab.

• Keep out of sight and reach of pets and children
• Store protected from light at a temperature not exceeding 30°C.

Safety Advices   Pregnancy  

Cazanat 40mg is unsafe to use during pregnancy as it may harm the unborn baby. Report to your doctor if you are pregnant or think you may be pregnant or planning for the pregnancy before starting the treatment.   

Breast Feeding  

Taking Cazanat 40mg while breastfeeding may be unsafe because it may affect the child. Do not breastfeed for at least four months after the treatment. Therefore, talk with your doctor to get more information.   

Lungs  

It is unknown whether Cazanat 40mg is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  

Liver

Inform your physician if you have liver problems because Cazanat 40mg should be used cautiously with this condition.  

Alcohol

It is unknown whether consuming alcohol while taking a Cazanat 40mg tablet is safe. Please speak with your physician.  

Driving

While taking Cazanat 40mg, driving or using machines is unsafe because it may cause nausea, changes in vision, vomiting, etc. Talk to your doctor for more information. 

Side Effects

• Gastrointestinal perforation
• Severe or uncontrollable bleeding
• Shortness of breath
• Nonhealing wound
• Pain in the mouth, jaw/teeth, hand, feet,
• Loss of consciousness,
• Drowsy
• Swelling or sores in the mouth
• Blood vomiting
• Black stools
• Blood in urine
• Headache
• Coughing blood

• Dehydration
• Difficulty swallowing
• Ringing in the ears
• Blood clots in the veins
• Fluctuation in the blood sugar levels
• The lower level of albumin
• Electrolyte imbalance
• Increased levels of liver enzymes
• Elevated cholesterol levels in the blood
• Hair loss
• Changes in hair color
• Muscle spasm
• Skin thickening
• Dry skin
• Itching
• Protein in urine

Strength	60 mg
Usage/Application	Personal
Form	Tablet
Composition	Cabozantinib 60mg
Compostion	Cabozantinib 60mg
Usage	Treatment of liver cancer, kidney cancer, and thyroid cancer.
Storage Condition	Store below 30 degree
Salt	Cabozantinib
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Cazanat 60mg tablet is an antineoplastic drug with an active ingredient called Cabozantinib. It belongs to the medication class known as tyrosine kinase inhibitors. In adults, it is used to treat advanced kidney cancer and locally advanced or metastatic differentiated thyroid cancer. It is also used in treating liver cancer when Sorafenib (anticancer medicine) is no longer working. Usually, this medicine is given in combination with Nivolumab for advanced kidney cancer. It is not recommended for those younger than 18 years.  

Do not consume Cazanat 60mg if you are allergic to Cabozantinib and its other ingredients. Inform your physician if you have liver disease, inflammatory bowel disease, high blood pressure, heart disease, or diarrhea. Notify your doctor about the history of blood clots in the leg or significant bleeding, aneurysm (inflammation of blood vessels), or tears in the blood vessel wall. Inform your physician if you are pregnant or planning to get pregnant. Use effective contraception during and even after the treatment or four months. Discuss more fertility concerns with your doctor. 

Uses

• Advanced renal cell carcinoma
• Liver Cancer
• Differentiated thyroid cancer

Therapeutic Effects

It acts against a protein called receptor tyrosine kinases and interferes with cell signaling, ultimately stopping the growth and spread of cancer cells. Cazanat 60mg is indicated alone or in combination with Nivolumab.

• Keep out of sight and reach of pets and children
• Store protected from light at a temperature not exceeding 30°C.

Safety Advices   Pregnancy  

Cazanat 60mg is unsafe to use during pregnancy as it may harm the unborn baby. Report to your doctor if you are pregnant or think you may be pregnant or planning for the pregnancy before starting the treatment.   

Breast Feeding  

Taking Cazanat 60mg while breastfeeding may be unsafe because it may affect the child. Do not breastfeed for at least four months after the treatment. Therefore, talk with your doctor to get more information.   

Lungs  

It is unknown whether Cazanat 60mg is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  

Liver  

Inform your physician if you have liver problems because Cazanat 60mg should be used cautiously with this condition.  

Alcohol  

It is unknown whether consuming alcohol while taking a Cazanat 60mg tablet is safe. Please speak with your physician.  

Driving  

While taking Cazanat 60mg, driving or using machines is unsafe because it may cause nausea, changes in vision, vomiting, etc. Talk to your doctor for more information. 

Side Effects

• Gastrointestinal perforation
• Severe or uncontrollable bleeding
• Shortness of breath
• Nonhealing wound
• Pain in the mouth, jaw/teeth, hand, feet,
• Loss of consciousness,
• Drowsy
• Swelling or sores in the mouth
• Blood vomiting
• Black stools
• Blood in urine
• Headache
• Coughing blood

• Dehydration
• Difficulty swallowing
• Ringing in the ears
• Blood clots in the veins
• Fluctuation in the blood sugar levels
• The lower level of albumin
• Electrolyte imbalance
• Increased levels of liver enzymes
• Elevated cholesterol levels in the blood
• Hair loss
• Changes in hair color
• Muscle spasm
• Skin thickening
• Dry skin
• Itching
• Protein in urine

Strength	20 mg
Usage/Application	Personal
Form	Tablet
Composition	Cabazitaxel 20mg
Compostion	Cabazitaxel 20mg
Usage	Treatment of liver cancer, kidney cancer, and thyroid cancer.
Storage Condition	Store below 30 degree
Salt	Cabazitaxel
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Cabdual 20mg tablet is an antineoplastic drug with an active ingredient called Cabozantinib. It belongs to the medication class known as tyrosine kinase inhibitors. In adults, it is used to treat advanced kidney cancer and locally advanced or metastatic differentiated thyroid cancer. It is also used in treating liver cancer when Sorafenib (anticancer medicine) is no longer working. Usually, this medicine is given in combination with Nivolumab for advanced kidney cancer. It is not recommended for those younger than 18 years.  

Do not consume Cabdual 20mg if you are allergic to Cabozantinib and its other ingredients. Inform your physician if you have liver disease, inflammatory bowel disease, high blood pressure, heart disease, or diarrhea. Notify your doctor about the history of blood clots in the leg or significant bleeding, aneurysm (inflammation of blood vessels), or tears in the blood vessel wall. Inform your physician if you are pregnant or planning to get pregnant. Use effective contraception during and even after the treatment or four months. Discuss more fertility concerns with your doctor. 

Uses

• Advanced renal cell carcinoma
• Liver Cancer
• Differentiated thyroid cancer

Therapeutic Effects

It acts against a protein called receptor tyrosine kinases and interferes with cell signaling, ultimately stopping the growth and spread of cancer cells. Cabdual 20mg is indicated alone or in combination with Nivolumab.

• Keep out of sight and reach of pets and children
• Store protected from light at a temperature not exceeding 30°C.

Safety Advices  Pregnancy  

Cabdual 20mg is unsafe to use during pregnancy as it may harm the unborn baby. Report to your doctor if you are pregnant or think you may be pregnant or planning for the pregnancy before starting the treatment.   

Breast Feeding 

Taking Cabdual 20mg while breastfeeding may be unsafe because it may affect the child. Do not breastfeed for at least four months after the treatment. Therefore, talk with your doctor to get more information.   

Lungs  

It is unknown whether Cabdual 20mg is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  

Liver  

Inform your physician if you have liver problems because Cabdual 20mg should be used cautiously with this condition.  

Alcohol  

It is unknown whether consuming alcohol while taking a Cabdual 20mg tablet is safe. Please speak with your physician.  

Driving  

While taking Cabdual 20mg, driving or using machines is unsafe because it may cause nausea, changes in vision, vomiting, etc. Talk to your doctor for more information. 

Side Effects

• Gastrointestinal perforation
• Severe or uncontrollable bleeding
• Shortness of breath
• Nonhealing wound
• Pain in the mouth, jaw/teeth, hand, feet,
• Loss of consciousness,
• Drowsy
• Swelling or sores in the mouth
• Blood vomiting
• Black stools
• Blood in urine
• Headache
• Coughing blood

• Dehydration
• Difficulty swallowing
• Ringing in the ears
• Blood clots in the veins
• Fluctuation in the blood sugar levels
• The lower level of albumin
• Electrolyte imbalance
• Increased levels of liver enzymes
• Elevated cholesterol levels in the blood
• Hair loss
• Changes in hair color
• Muscle spasm
• Skin thickening
• Dry skin
• Itching
• Protein in urine

Strength	0.25 mg
Usage/Application	Personal
Form	Tablet
Drug Name	Certican Everolimus 0.25mg Tablet
Generic Name	Everolimus
Compostion	Everolimus 0.25mg
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Certican 0.25mg tablet is an antineoplastic drug belonging to the class of mTOR kinase inhibitors, containing the active ingredient everolimus. It is used to treat advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and also in the treatment of subependymal giant cell astrocytoma (tumors are found in the ventricles of the brain). Good oral hygiene and regular dental check-ups are important during the treatment since this medicine can cause sores or ulcers in the mouth. It is often combined with cyclophosphamide, an alkylating agent, to treat subependymal giant cell astrocytoma. 

This tablet is not recommended for adolescents and children under the age of 18. Contact your doctor immediately if you experience shortness of breath, chest pain, or worsening cough. During the Certican 0.25mg tablet treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. This medicine has the potential to cause kidney problems. Report to your doctor if you have been diagnosed with liver disorders, heart failure, high blood cholesterol levels, or hypertension before starting this treatment. Avoid live vaccines and close contact with those who have received live vaccines.

Uses

• Advanced breast cancer
• Advanced renal cell carcinoma
• Advanced pancreatic neuroendocrine tumours
• Treatment of subependymal giant cell astrocytoma

Therapeutic Effects

Certican 0.25mg tablet inhibits the activity of a protein called mammalian target of rapamycin (mTOR), which regulates cell growth. This drug can slow the growth of abnormal cancer cells by blocking the mTOR protein and helps to reduce the size of tumors and improve outcomes in patients.

• Store Certican 0.25mg tablet in the original package at room temperature (20°C to 25°C).
• Keep it out of reach from children.

Safety Advices  Pregnancy  

Certican 0.25mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.  

Breast Feeding  

Certican 0.25mg tablet passes into your breast milk and harms your baby. It is unsafe to consume this tablet.  

Lungs  

It is not known whether Certican 0.25mg tablet can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

Inform your doctor if you have any liver problems before taking Certican 0.25mg tablet. Regular monitoring of liver function tests is recommended.

Alcohol  

Consuming alcohol may affect the effectiveness of Certican 0.25mg tablet. Stop consuming alcohol if you are taking this medicine.  

Driving  

It is unsafe to drive vehicles or operate heavy machinery after taking Certican 0.25mg tablet, it may cause dizziness and impair your concentration.

Side Effects

• Difficulty breathing, or swallowing
• Swelling of face, lips, tongue, throat
• Severe itching, red rash, raised bumps

• Infection (chills, increased temperature)
• Coughing
• Wheezing
• Excessive thirst
• High urine output or severely decreased urine output
• Tiredness
• Bleeding
• Increased appetite with weight loss

Strength	0.5 mg
Usage/Application	Personal
Form	Tablet
Drug Name	Everolimus 0.5mg
Generic Name	Everolimus
Compostion	Everolimus 0.5mg
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Certican 0.5mg tablet is an antineoplastic drug belonging to the class of mTOR kinase inhibitors, containing the active ingredient everolimus. It is used to treat advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and also in the treatment of subependymal giant cell astrocytoma (tumors are found in the ventricles of the brain). Good oral hygiene and regular dental check-ups are important during the treatment since this medicine can cause sores or ulcers in the mouth. It is often combined with cyclophosphamide, an alkylating agent, to treat subependymal giant cell astrocytoma. 

Before taking this medicine, it is necessary to know that your risk of getting bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, Certican 0.5mg tablet increases the chances of reinfection. Tell your healthcare provider if you experience fever, chills, cough, yellowing of the skin, joint pain, or swelling during this treatment. You must limit your exposure to sunlight and UV light by wearing protective clothing and applying sunscreen frequently, as this medicine may increase the risk of developing cancers. Avoid taking grapefruit juice or grapefruit while taking this medicine. 

This tablet is not recommended for adolescents and children under the age of 18. Contact your doctor immediately if you experience shortness of breath, chest pain, or worsening cough. During the Certican 0.5mg tablet treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. This medicine has the potential to cause kidney problems. Report to your doctor if you have been diagnosed with liver disorders, heart failure, high blood cholesterol levels, or hypertension before starting this treatment. Avoid live vaccines and close contact with those who have received live vaccines.

Uses

• Advanced breast cancer
• Advanced renal cell carcinoma
• Advanced pancreatic neuroendocrine tumours
• Treatment of subependymal giant cell astrocytoma

• Store Certican 0.5mg tablet in the original package at room temperature (20°C to 25°C).

Safety Advices  Pregnancy  

Certican 0.5mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.  

Breast Feeding  

Certican 0.5mg tablet passes into your breast milk and harms your baby. It is unsafe to consume this tablet.  

Lungs

It is not known whether Certican 0.5mg tablet can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver

Inform your doctor if you have any liver problems before taking Certican 0.5mg tablet. Regular monitoring of liver function tests is recommended.  

Alcohol

Consuming alcohol may affect the effectiveness of Certican 0.5mg tablet. Stop consuming alcohol if you are taking this medicine.  

Driving

It is unsafe to drive vehicles or operate heavy machinery after taking Certican 0.5mg tablet, it may cause dizziness and impair your concentration.

Side Effects

• Difficulty breathing, or swallowing
• Swelling of face, lips, tongue, throat
• Severe itching, red rash, raised bumps

• Infection (chills, increased temperature)
• Coughing
• Wheezing
• Excessive thirst
• High urine output or severely decreased urine output
• Tiredness
• Bleeding
• Increased appetite with weight loss

Usage/Application	Personal
Form	Tablet
Drug Name	Everolimus 0.75mg
Generic Name	Everolimus
Compostion	Everolimus 0.75mg
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Certican 0.75mg tablet is an antineoplastic drug belonging to the class of mTOR kinase inhibitors, containing the active ingredient everolimus. It is used to treat advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and also in the treatment of subependymal giant cell astrocytoma (tumors are found in the ventricles of the brain). Good oral hygiene and regular dental check-ups are important during the treatment since this medicine can cause sores or ulcers in the mouth. It is often combined with cyclophosphamide, an alkylating agent, to treat subependymal giant cell astrocytoma. 

Before taking this medicine, it is necessary to know that your risk of getting bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, Certican 0.75mg tablet increases the chances of reinfection. Tell your healthcare provider if you experience fever, chills, cough, yellowing of the skin, joint pain, or swelling during this treatment. You must limit your exposure to sunlight and UV light by wearing protective clothing and applying sunscreen frequently, as this medicine may increase the risk of developing cancers. Avoid taking grapefruit juice or grapefruit while taking this medicine. 

This tablet is not recommended for adolescents and children under the age of 18. Contact your doctor immediately if you experience shortness of breath, chest pain, or worsening cough. During the Certican 0.75mg tablet treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. This medicine has the potential to cause kidney problems. Report to your doctor if you have been diagnosed with liver disorders, heart failure, high blood cholesterol levels, or hypertension before starting this treatment. Avoid live vaccines and close contact with those who have received live vaccines.

Uses of Certican 0.75mg Tablet

• Advanced breast cancer
• Advanced renal cell carcinoma
• Advanced pancreatic neuroendocrine tumours
• Treatment of subependymal giant cell astrocytoma

• Store Certican 0.75mg tablet in the original package at room temperature (20°C to 25°C).
• Keep it out of reach from children.

Safety Advices Pregnancy  

Certican 0.75mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.  

Breast Feeding  

Certican 0.75mg tablet passes into your breast milk and harms your baby. It is unsafe to consume this tablet.  

Lungs  

It is not known whether Certican 0.75mg tablet can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

Inform your doctor if you have any liver problems before taking Certican 0.75mg tablet. Regular monitoring of liver function tests is recommended.  

Alcohol  

Consuming alcohol may affect the effectiveness of Certican 0.75mg tablet. Stop consuming alcohol if you are taking this medicine.  

Driving  

It is unsafe to drive vehicles or operate heavy machinery after taking Certican 0.75mg tablet, it may cause dizziness and impair your concentration.

Side Effects

• Difficulty breathing, or swallowing
• Swelling of face, lips, tongue, throat
• Severe itching, red rash, raised bumps

• Infection (chills, increased temperature)
• Coughing
• Wheezing
• Excessive thirst
• High urine output or severely decreased urine output
• Tiredness
• Bleeding
• Increased appetite with weight loss

Strength	20 mg
Brand	Dash
Tablets per Pack	60 Tablets
Usage/Application	Personal
Pack Size	1*10 Tablet
Pack Type	Box
Usage	CML
Pack Type	Bottle
Form	Tablet
Compostion	Dasatinib 20mg
Brand Name	Dash Tablet
Manufacturer	BDR PHARMACEUTICALS INTERNATIONALS PVT LTD
Usages	It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia
Country of Origin	Made in India

Dash 20mg tablet consists of the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase and Ph+ acute lymphoblastic leukemia in patients resistant to other therapies. Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body produce too many white blood cells that happen due to alteration in the Philadelphia chromosome. Acute Lymphoblastic Leukemia is the most common form of blood cancer that affects children. In this case, the lymphocytes of white blood cells multiply too quickly and live too long.

The common side effects that are likely to associate with Dash 20mg tablet are diarrhea, headache, cough, rash, nausea, tiredness, vomiting, muscle pain, weakness, low appetite, high or low blood pressure. Inform your doctor if these side effects disturb or persist for longer period.

Inform your doctor if you are allergic to Dash 20mg and its ingredients. Before starting treatment with this medication, you should let your physician know if you have liver or heart problems, breathing difficulties, chest pain, cough, hepatitis B infection, bleeding problems. This medicine could cause a severe reduction in the number of platelets, WBC or RBC in the blood. Ensure that your physician monitors your blood levels at regular intervals. Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter medicines, vitamins, antacids, and herbal supplements. It is not recommended for children below one year of age.

Uses of Dash 20mg Tablet

Dash 20mg tablet is indicated for the following conditions:

• Children and adults with chronic myeloid leukemia.
• Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.

More Information

Store protected from light at a temperature not exceeding 30c.

Pregnancy 

Dash 20mg tablet is not recommended to use during pregnancy unless clearly necessary. Your physician will discuss the potential risk during pregnancy. Women should use effective birth control during treatment and 30 days after the final dose.   

Breast Feeding  

It is not recommended to breastfeed while taking Dash 20mg tablet as it is not known whether this medication passes into breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose.  

Lungs  

It is unknown whether Dash 20mg is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.  

Liver  

Inform your physician before starting this treatment if you have liver diseases. Your physician will prescribe a dose accordingly.  

Alcohol  

It is not known whether it is safe to consume alcohol with Dash 20mg tablet. Consult your doctor for advice.  

Driving  

Avoid driving or using machinery if you experience symptoms like breathlessness or altered consciousness. 

Side Effects

• Unusual bleeding or bruising
• Rapid heart rate
• Changes in consciousness or speech
• Breathlessness and swelling all over the body
• Fever or signs of infection
• Fluid retention
• Heart problems
• Myelosuppression
• Severe allergic reaction

• Diarrhea
• Headache
• Cough
• Rash
• Nausea, tiredness, vomiting
• Muscle pain, weakness
• Low appetite
• High or low BP

Strength	100 mg
Dose/Strength	100 mg/ 20 ml
Vial Volume	10 ml
Company	BDR
Usage/Application	Personal
Form	Injection
Packaging Type	Vial
Shelf Life	24 months
Compostion	Oxaliplatin 100mg
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Manufacturer	BDR Pharmaceuticals Internationals Pvt

Oxaliptin 100mg Injection belongs to the group of medications called platinum-based antineoplastic agents. It consists of the active ingredient Oxaliplatin. It is prescribed to treat stage 3 colon cancer after resectioning (surgical removal) of the primary tumor, metastatic colon and rectum cancer. It is used in combination with other anti-cancer medicines. Colorectal cancer is cancer that usually develops in the rectum and large intestine. It develops from the accumulation of various genetic mutations. Both environmental and genetic factors play a significant role in the origin of colorectal cancer. This medicine works against tumors that are resistant to cisplatin therapy.

The common side effects that are likely to associate with Oxaliptin 100mg Injection are a reduced number of blood cells, unpleasant sensation in the throat, diarrhea, nausea, vomiting, indigestion, heartburn, blood clots, blood in urine, high blood pressure, depression, insomnia, low calcium level. Inform your doctor if these side effects disturb or persist in you.

Inform your doctor if you are allergic to Oxaliptin 100mg Injection and its ingredients. Before starting treatment with this medication, inform your physician if you have moderate or mild kidney problems, liver problems, or heart disorders. Tell your doctor about all the medicines you are taking, including vaccinations. It is not recommended for pregnant and breastfeeding women.   

Uses

• Treatment of colon and rectal cancer.

• Store at a temperature below 30°C.
• Protect from light.

Safety Advices  Pregnancy  

Oxaliptin 100mg Injection is unsafe to use during pregnancy; hence it is not recommended. Women should use effective contraception during and after the 4 months of treatment.   

Breast Feeding  

It is unsafe to breastfeed during treatment with Oxaliptin 100mg Injection. Your physician might suggest you stop breastfeeding for some time, depending on your condition.  

Lungs  

Inform your physician before taking Oxaliptin 100mg Injection if you have if you have any lung conditions.   

Liver 

Inform your physician before starting treatment with Oxaliptin 100mg Injection if you have liver disease or abnormal liver function. Your physician will prescribe the dose accordingly.  

Alcohol  

It is unknown whether it is safe to consume alcohol with Oxaliptin 100mg Injection. Consult your doctor for any concerns regarding this.  

Driving  

Avoid driving or using machinery if you experience side effects like dizziness, nausea, vomiting, vision problems, and other neurological symptoms.

Side Effects

• Abnormal bleeding or bruising
• Severe allergic reactions
• Continuous diarrhea and vomiting
• Sore throat and fever
• Irregular heartbeat
• Muscle pain and weakness
• Mouth ulcers
• Extreme tiredness and breathlessness
• Headache
• Altered mental function
• Blurred vision
• Seizures

• A reduced number of blood cells
• Unpleasant sensation in the throat
• Diarrhea
• Nausea, vomiting
• High risk of infections
• Indigestion and heartburn
• Blood in urine
• Blood clots
• High BP
• Depression and insomnia
• Low levels of calcium in the blood

Strength	2.5 mg
Vial Volume	1 vial
Brand	Bortecad
Usage/Application	Personal
Composition	Bortezomib 2 mg
Route of Administration	IV
Indication	Multiple Myeloma
Compostion	Bortezomib 2.5mg
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Form	Injection
Country of Origin	Made in India

Bortecad 2.5mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant. 

Inform your doctor if you are allergic to Bortecad 2.5mg  Injection and its ingredients. Do not use this medication if you have severe lung or heart problems. Before starting treatment with this medication, let your physician know if you are suffering from neuropathy (nerves malfunction), cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumor lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Inform your doctor of diabetes because this Injection can affect your blood glucose levels.

Uses

• Treatment of multiple myeloma and mantle cell lymphoma.

• Store unopened vials in the refrigerator (2 °C – 8 °C) and protect them from light.
• Keep this medicine out of sight and reach of children.

Safety Advices  Pregnancy  

Bortecad 2.5mg Injection is unsafe to use during pregnancy unless clearly necessary. Both women of childbearing potential and men must use an effective contraception method during and three months after treatment.  

Breast Feeding  

Bortecad 2.5mg Injection is unsafe to use during breastfeeding. Please discuss with your physician when it is safe to restart breastfeeding after this treatment.  

Lungs 

It is unknown whether Bortecad 2.5mg Injection can be given to lung failure patients. Please consult your physician if you have any lung diseases.   

Liver  

Inform your physician before starting this treatment if you have Hepatitis infection or liver disease. Your physician will monitor your liver functions regularly.

Alcohol  

It is unsafe to consume alcohol with this medication. Bortecad 2.5mg Injection may cause excessive drowsiness with alcohol. Please consult your doctor for more advice.  

Driving  

Avoid driving or using machinery if you experience side effects like fainting, dizziness, tiredness, or blurred vision.

Side Effects

• Muscle cramps
• Confusion, visual disturbances, seizures, and headache
• Breathlessness
• Swelling of feet
• Changes in heartbeat
• High blood pressure
• Fainting and tiredness
• Cough and chest tightness

• Pneumonia
• Loss of appetite
• Sensitivity, tingling and burning sensation of the skin
• Nausea, vomiting, and diarrhea
• Mouth ulcers
• Constipation
• Muscle and bone pain
• Hair loss
• Fever
• Reduction in blood cell count
• Reduced kidney function
• Shivering
• Infections
• Itching and redness
• Dehydration
• Stomach problems
• Difficulty sleeping, anxiety, mood swings, depressed mood

Strength	20 mg
Pack Size	5 capsules
Company	MSD
Usage/Application	Personal
Brand	Temodal
Usage	Brain tumor
Shelf Life	24 months
Drug name	Temozolomide 20mg
Compostion	Temozolomide
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Temodal 20mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Temodal 20mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Temodal 20mg Capsule, and it is continued as maintenance therapy.

The common side effects that are likely to associate with Temodal 20mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.

Uses

•  Treatment of newly diagnosed glioblastoma multiforme.
• Treatment of refractory anaplastic astrocytoma

More Information

• Keep Temodal 20mg Capsule out of sight and reach of children.
• Store protected from light and moisture.
• Do not store above 25°C.

Safety Advices Pregnancy

Temodal 20mg Capsule is unsafe to use during pregnancy as it may cause fetal harm. It should not be used unless prescribed by your physician. Women with childbearing potential should use effective contraceptive precautions for at least 6 months following the completion of treatment.   

Breast Feeding

Temodal 20mg Capsule is unsafe to use during breastfeeding as it passes through breast milk and harm the baby. Consult your physician for advice before breastfeeding.  

Lungs

Inform your physician before taking Temodal 20mg Capsule if you have if you have any lung conditions.   

Liver

Inform your physician before taking Temodal 20mg Capsule if you have severe liver problems. Dose adjustment is required based on the condition.   

Alcohol

Avoid consuming alcohol while taking Temodal 20mg Capsule as it may cause unpleasant side effects. Consult our doctor for advice.  

Driving

Do not drive or operate heavy machines while being treated with Temodal 20mg Capsule as it may decrease alertness, affect your vision and make you dizzy and sleepy. 

Side Effects

• Secondary cancer like myelodysplastic syndrome and myeloid leukemia.
• Severe Allergic reactions
• Inflammation and fluid buildup in lungs
• Blood clot in lungs or legs
• Liver toxicity
• Convulsions
• Fever and chills
• Severe headache
• Uncontrolled bleeding

• Hair loss
• Rashes
• Tiredness
• Nausea, vomiting and diarrhea
• Constipation
• High blood sugar levels
• Dizziness, impaired sensation, tingling sensation, abnormal taste
• Vision and Hearing problem
• Frequent urination
• Muscle damage, pain in muscles and joints
• Weight changes
• Infections and wounds
• Amnesia
• Abnormal blood cell counts
• Loss of appetite
• Sleep problems
• Memory loss
• Difficulty concentrating, changes in mental status and alertness
• Coordination problems